<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57553</article-id><article-id pub-id-type="doi">10.7554/eLife.57553</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title><italic>PTPRG</italic> is an ischemia risk locus essential for HCO<sub>3</sub><sup>–</sup>-dependent regulation of endothelial function and tissue perfusion</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-182610"><name><surname>Hansen</surname><given-names>Kristoffer B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182611"><name><surname>Staehr</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182612"><name><surname>Rohde</surname><given-names>Palle D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4347-8656</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206722"><name><surname>Homilius</surname><given-names>Casper</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182613"><name><surname>Kim</surname><given-names>Sukhan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182614"><name><surname>Nyegaard</surname><given-names>Mette</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127353"><name><surname>Matchkov</surname><given-names>Vladimir V</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3303-1095</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-181974"><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5078-9279</contrib-id><email>eb@biomed.au.dk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biomedicine, Aarhus University</institution><addr-line><named-content content-type="city">Aarhus</named-content></addr-line><country>Denmark</country></aff><aff id="aff2"><label>2</label><institution>Department of Chemistry and Bioscience, Aalborg University</institution><addr-line><named-content content-type="city">Aalborg</named-content></addr-line><country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mangoni</surname><given-names>Arduino A</given-names></name><role>Reviewing Editor</role><aff><institution>Flinders Medical Centre</institution><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barton</surname><given-names>Matthias</given-names></name><role>Senior Editor</role><aff><institution>University of Zurich</institution><country>Switzerland</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>21</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e57553</elocation-id><history><date date-type="received" iso-8601-date="2020-04-03"><day>03</day><month>04</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-18"><day>18</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Hansen et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Hansen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57553-v2.pdf"/><abstract><p>Acid-base conditions modify artery tone and tissue perfusion but the involved vascular-sensing mechanisms and disease consequences remain unclear. We experimentally investigated transgenic mice and performed genetic studies in a UK-based human cohort. We show that endothelial cells express the putative HCO<sub>3</sub><sup>–</sup>-sensor receptor-type tyrosine-protein phosphatase RPTPγ, which enhances endothelial intracellular Ca<sup>2+</sup>-responses in resistance arteries and facilitates endothelium-dependent vasorelaxation only when CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> is present. Consistent with waning RPTPγ-dependent vasorelaxation at low [HCO<sub>3</sub><sup>–</sup>], RPTPγ limits increases in cerebral perfusion during neuronal activity and augments decreases in cerebral perfusion during hyperventilation. RPTPγ does not influence resting blood pressure but amplifies hyperventilation-induced blood pressure elevations. Loss-of-function variants in <italic>PTPRG</italic>, encoding RPTPγ, are associated with increased risk of cerebral infarction, heart attack, and reduced cardiac ejection fraction. We conclude that <italic>PTPRG</italic> is an ischemia susceptibility locus; and RPTPγ-dependent sensing of HCO<sub>3</sub><sup>–</sup> adjusts endothelium-mediated vasorelaxation, microvascular perfusion, and blood pressure during acid-base disturbances and altered tissue metabolism.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Restricted blood flow in the heart or brain can deprive these vital organs of oxygen, thereby causing a heart attack or stroke. However, the body has compensatory mechanisms to mitigate damage: if the blood flow is reduced in one blood vessel, acidic waste accumulates locally. This causes nearby blood vessels to widen and increase the oxygen supply. Although scientists first observed this process 140 years ago, they have not yet devised a way to use it for treatment of heart attack or stroke.</p><p>Now, Hansen et al. discovered that a protein called RPTPγ, which is found on the lining of blood vessels, could be a good target for drugs intended to reduce the consequences of heart attacks and strokes. The protein RPTPγ has a similar structure to other proteins that bind bicarbonate, an important ion that buffers acids in the body. RPTPγ can also trigger signals to nearby cells, which suggests that the protein can monitor bicarbonate levels in the blood and tissue and alert blood vessels of the need to widen.</p><p>Hansen et al. found that the blood vessels of mice that lacked RPTPγ were unable to widen when needed. Moreover, mice without RPTPγ experienced abnormal changes in blood pressure and blood flow to the brain when oxygen consumption was elevated or pH was disrupted. Hansen et al. further analyzed genetic and health data from nearly 50,000 individuals in the UK Biobank. These analyses revealed that people with genetic changes that render RPTPγ ineffective are at higher risk of having a heart attack or stroke. People with these genetic variants also have reduced heart pumping ability.</p><p>The experiments suggest that a lack of functional RPTPγ affects an individual’s ability to adjust local blood flow in response to acid-base disturbances and oxygen deficits, increasing the risk of a heart attack or stroke. This information may help scientists develop new ways to prevent or treat heart attacks and strokes, or to treat other conditions like cancer, where pH is disturbed.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>acidosis</kwd><kwd>bicarbonate</kwd><kwd>cerebral blood flow and metabolism</kwd><kwd>endothelium-dependent vasorelaxation</kwd><kwd>metabolic regulation</kwd><kwd>ischemia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004836</institution-id><institution>Det Frie Forskningsråd</institution></institution-wrap></funding-source><award-id>4183-00258B</award-id><principal-award-recipient><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004836</institution-id><institution>Det Frie Forskningsråd</institution></institution-wrap></funding-source><award-id>7025-00050A</award-id><principal-award-recipient><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003554</institution-id><institution>Lundbeckfonden</institution></institution-wrap></funding-source><award-id>R93-A8859</award-id><principal-award-recipient><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003554</institution-id><institution>Lundbeckfonden</institution></institution-wrap></funding-source><award-id>R287-2018-735</award-id><principal-award-recipient><name><surname>Rohde</surname><given-names>Palle D</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>MEMBRANES Research Center</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Boedtkjer</surname><given-names>Ebbe</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>HCO<sub>3</sub><sup>–</sup>-sensitive regulation of endothelium-dependent vasorelaxation by receptor-type tyrosine-protein phosphatase RPTPγ provides a novel mechanism for acid-base-mediated coordination of cerebrovascular perfusion during increased local metabolism and for protection against ischemia.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Inadequate tissue perfusion relative to metabolic demand is a fundamental pathophysiological cause of acute (e.g. myocardial infarction and stroke) and chronic (e.g. heart failure and neurodegenerative disorders) cardiovascular disease. Newer treatment options improve the prognosis for some of these debilitating conditions but we need alternative therapeutic strategies in order to minimize ischemia-related morbidity and mortality.</p><p>Sensing of the chemical environment in the wall of arteries coordinates local blood flow to meet the oxidative metabolic demand and counteract ischemia. Despite their obvious clinical importance, the cellular and molecular mechanisms responsible for sensing metabolic disturbances and responding to inadequate perfusion are not well understood (<xref ref-type="bibr" rid="bib17">Boedtkjer, 2018</xref>). Local acidification is an important signal of insufficient nutrient delivery and waste product elimination. Although functional effects of H<sup>+</sup> in the vascular wall have long been appreciated (<xref ref-type="bibr" rid="bib17">Boedtkjer, 2018</xref>; <xref ref-type="bibr" rid="bib30">Gaskell, 1880</xref>; <xref ref-type="bibr" rid="bib14">Boedtkjer et al., 2016a</xref>; <xref ref-type="bibr" rid="bib19">Boedtkjer and Aalkjaer, 2012</xref>; <xref ref-type="bibr" rid="bib20">Boedtkjer and Aalkjaer, 2013a</xref>; <xref ref-type="bibr" rid="bib21">Boedtkjer and Aalkjaer, 2013b</xref>), the consequences of associated changes in CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> buffer composition have received far less attention. CO<sub>2</sub> and HCO<sub>3</sub><sup>–</sup> constitute an important buffer pair that minimizes acute changes in pH (<xref ref-type="bibr" rid="bib42">Roos and Boron, 1981</xref>), improves spatial H<sup>+</sup> mobility (<xref ref-type="bibr" rid="bib44">Spitzer et al., 2002</xref>; <xref ref-type="bibr" rid="bib15">Boedtkjer et al., 2016b</xref>), and provides substrate for acid-base transporters in cell membranes (<xref ref-type="bibr" rid="bib2">Aalkjaer and Hughes, 1991</xref>; <xref ref-type="bibr" rid="bib9">Boedtkjer et al., 2006</xref>). Evidence supports that cells also possess sensors that respond to changes in [HCO<sub>3</sub><sup>–</sup>] in the intracellular and extracellular space (<xref ref-type="bibr" rid="bib55">Zhou et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>; <xref ref-type="bibr" rid="bib26">Chen et al., 2000</xref>). Interventions—such as NaHCO<sub>3</sub> supplementation—that modify systemic acid-base status are available (<xref ref-type="bibr" rid="bib50">Voss et al., 2020</xref>) but expected to carry considerable adverse effects and be too general for cardiovascular therapy. The identification of HCO<sub>3</sub><sup>–</sup>-related proteins (e.g. carbonic anhydrases, Na<sup>+</sup>,HCO<sub>3</sub><sup>–</sup>-cotransporters, Cl<sup>–</sup>/HCO<sub>3</sub><sup>–</sup>-exchangers, and HCO<sub>3</sub><sup>–</sup>-sensors) opens largely unexplored avenues for pharmacological treatment. Because the vasculature of vital organs—particularly the brain and heart—responds to metabolic deregulation and is sensitive to acid-base disturbances, it is likely that therapy targeting HCO<sub>3</sub><sup>–</sup>-related proteins will be able to modify myocardial and cerebral perfusion preferentially in areas of unmet metabolic demand.</p><p>Through mechanisms that require the transmembrane Receptor Protein Tyrosine Phosphatase (RPTP)γ, isolated decreases in extracellular [HCO<sub>3</sub><sup>–</sup>] enhance HCO<sub>3</sub><sup>–</sup> reabsorption in the renal proximal tubule (<xref ref-type="bibr" rid="bib55">Zhou et al., 2016</xref>) and contractions of basilar arteries (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>) when pCO<sub>2</sub> and pH are kept constant using out-of-equilibrium technology (<xref ref-type="bibr" rid="bib54">Zhao et al., 1995</xref>). The extracellular domain of RPTPγ resembles the active site of the carbonic anhydrases (<xref ref-type="bibr" rid="bib6">Barnea et al., 1993</xref>) and therefore likely binds HCO<sub>3</sub><sup>–</sup>. However, the carbonic anhydrase-like domain of RPTPγ lacks the histidine residues considered essential for catalyzing equilibration of the reaction: <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mo stretchy="false">⇄</mml:mo><mml:mi mathvariant="normal">H</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mrow><mml:msub><mml:mi/><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mi/><mml:mo>−</mml:mo></mml:msup></mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="normal">H</mml:mi><mml:mrow><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> (<xref ref-type="bibr" rid="bib55">Zhou et al., 2016</xref>). Instead, HCO<sub>3</sub><sup>–</sup> may induce a dimerization-dependent auto-inhibitory response in RPTPγ and thereby regulate signaling via the intracellular tyrosine phosphatase domains (<xref ref-type="bibr" rid="bib7">Barr et al., 2009</xref>). Apart from these structural observations, we do not currently understand the cellular and molecular mechanisms for impact of HCO<sub>3</sub><sup>–</sup> and RPTPγ on resistance artery function, blood pressure, and control of tissue perfusion. Although CO<sub>2</sub> has no direct net effect on cerebrovascular tone (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>), respiratory changes leading to hyper- or hypocapnia will lead to secondary rises or falls in [HCO<sub>3</sub><sup>–</sup>] and pH that in turn influence artery contractions and tissue perfusion.</p><p>In the present study, we demonstrate—based on experimental investigations in transgenic mice—that RPTPγ (a) facilitates endothelium-dependent relaxation of resistance arteries through mechanisms regulated by extracellular HCO<sub>3</sub><sup>–</sup> and (b) adjusts microvascular perfusion and blood pressure during increased tissue metabolism and acid-base disturbances. Through translational genetic studies in the UK Biobank cohort (<xref ref-type="bibr" rid="bib24">Bycroft et al., 2018</xref>), we further substantiate the importance of the identified mechanisms for human cardiovascular health as we demonstrate that predicted loss-of-function variants in <italic>PTPRG</italic>, encoding RPTPγ, are associated with human ischemic vascular disease in the heart and brain.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Ptprg</italic> is widely expressed in the vascular endothelium</title><p>We first evaluated promoter activity for <italic>Ptprg</italic> by β-galactosidase staining of mice with a promoterless <italic>LacZ</italic> insert under transcriptional control of the <italic>Ptprg</italic> promoter. We found signs of prominent <italic>Ptprg</italic> transcriptional activity in the endothelium of mouse basilar, middle cerebral, and coronary arteries (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We also saw signs of <italic>Ptprg</italic> transcriptional activity in pulmonary and skeletal muscle arteries, whereas transcription of <italic>Ptprg</italic> appeared lower in the aorta and mesenteric arteries (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Profiles of <italic>Ptprg</italic> transcriptional activity and mRNA levels demonstrate widespread expression across arterial, capillary, and venous endothelial cells and in diverse vascular beds including cerebral and coronary arteries.</title><p>(<bold>A</bold>) Histochemical staining for β-galactosidase activity reports the <italic>Ptprg</italic> transcriptional activity in <italic>Ptprg<sup>LacZ/LacZ</sup></italic> mice. The scale bars indicate 5 and 50 µm for the histological and whole-mount images, respectively, and all images within each category are displayed at the same magnification except for the image of the aorta where the scale bar corresponds to 150 µm. The 4-µm-thick longitudinal histological sections illustrate basilar and middle cerebral arteries where the lumen is collapsed, and endothelial cells (EC) from opposing walls meet at the center and are surrounded by their adjacent tunica media (M). The images are representative of tissue from 4 <italic>Ptprg<sup>LacZ/LacZ</sup></italic> mice and 2 WT mice. (<bold>B</bold>) <italic>Ptprg</italic> mRNA levels in arteries from WT mice displayed relative to the ribosomal S18 and β-actin reference genes (n = 11) and normalized to the average level in basilar arteries. (<bold>C–E</bold>) Single-cell RNA sequencing data analyzed for endothelial <italic>Ptprg</italic> expression in healthy murine brain (3482 cells), heart (3219 cells), skeletal muscle (m. soleus, 2457 cells), lung (3972 cells), and small intestine (974 cells). Data are averaged across each vascular bed (<bold>C</bold>), displayed as t-SNE plots of <italic>Ptprg</italic> transcript patterns (left images) and clustered vessel types (right images) (<bold>D</bold>), and divided and quantified according to vessel type in each tissue (<bold>E</bold>). The single-cell RNA sequencing data are from the online EC Atlas database (<xref ref-type="bibr" rid="bib31">Kalucka et al., 2020</xref>). Data in panel <bold>B</bold> were compared after log-transformation using repeated-measures one-way ANOVA followed by Dunnett’s post-test. *p&lt;0.05, **p&lt;0.01, NS: not significantly different vs basilar arteries.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57553-fig1-v2.tif"/></fig><p>Since promoter activity is no direct measure of expression—and cytosolic dilution of the chromogenic reaction product lowers the sensitivity of the β-galactosidase reporter assay—we followed up with quantitative RT-PCR analyses that confirmed substantial steady-state levels of <italic>Ptprg</italic> mRNA in basilar, middle cerebral, coronary, and pulmonary arteries and identified clearly detectable levels in the aorta, mesenteric, and skeletal muscle arteries (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><p>We next explored the endothelial expression pattern of <italic>Ptprg</italic> based on single-cell transcriptomic data from healthy mice (<xref ref-type="bibr" rid="bib31">Kalucka et al., 2020</xref>). These data verify <italic>Ptprg</italic> expression in the vascular endothelium of the brain, heart, lung, skeletal muscle, and small intestine (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref>). The data further show that the endothelial <italic>Ptprg</italic> expression extends from the arterial vasculature, across capillaries, and into the veins (<xref ref-type="fig" rid="fig1">Figure 1D,E</xref>).</p><p>Taken together, we identify widespread endothelial <italic>Ptprg</italic> expression with prominent levels in the cerebral and coronary vasculature where metabolites, including acid-base equivalents, strongly influence arterial tone (<xref ref-type="bibr" rid="bib30">Gaskell, 1880</xref>; <xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>; <xref ref-type="bibr" rid="bib51">Wahl et al., 1970</xref>).</p></sec><sec id="s2-2"><title>RPTPγ enhances endothelium-dependent vasorelaxation</title><p>Isolated small arteries pre-contracted with the thromboxane A<sub>2</sub> analog U46619 relaxed concentration-dependently in response to the classical endothelium-dependent agonist acetylcholine (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In order to evaluate a distinct additional endothelial signaling pathway (<xref ref-type="bibr" rid="bib27">D'Andrea et al., 1998</xref>) capable of inducing potent endothelium-dependent vasorelaxation of cerebral and mesenteric small arteries (<xref ref-type="bibr" rid="bib13">Boedtkjer et al., 2013a</xref>; <xref ref-type="bibr" rid="bib37">McNeish et al., 2005</xref>; <xref ref-type="bibr" rid="bib23">Bucci et al., 2005</xref>), we also tested the effect of the proteinase-activated receptor (PAR)2 agonist SLIGRL-amide (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Acetylcholine (ACh)-induced endothelium-dependent vasorelaxation is compromised in basilar, mesenteric, and coronary arteries from RPTPγ KO mice when investigated in presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>.</title><p>(<bold>A</bold> and <bold>D</bold>) Force recordings illustrating acetylcholine-induced vasorelaxation of U46619-contracted basilar arteries under control conditions (<bold>A</bold>) and after treatment with 100 µM L-NAME (<bold>D</bold>). The pre-contraction force development in response to U46619 was normalized in order to display relative relaxations. (<bold>B</bold>, <bold>I</bold>, and <bold>M</bold>) Acetylcholine-induced relaxations of basilar (<bold>B</bold>, n = 7–9), mesenteric (<bold>I</bold>, n = 11–13), and coronary (<bold>M</bold>, n = 7) arteries from RPTPγ KO and WT mice under control conditions, i.e. without inhibitors of endothelial function. For mesenteric and coronary arteries, we applied a concentration of 0.5 and 3.0 µM acetylcholine, respectively. (<bold>C</bold>) Experiment similar to that in panel B but performed in a CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solution without HEPES (n = 9–10). (<bold>E</bold>, <bold>J</bold>, and <bold>N</bold>) Acetylcholine-induced relaxations of basilar (<bold>E</bold>, n = 7–9), mesenteric (<bold>J</bold>, n = 11–13), and coronary (<bold>N</bold>, n = 7) arteries from RPTPγ KO and WT mice after treatment with 100 µM L-NAME. For mesenteric and coronary arteries, we applied a concentration of 0.5 and 3.0 µM acetylcholine, respectively. (<bold>F</bold>, <bold>K</bold>, and <bold>O</bold>) Acetylcholine-induced L-NAME-sensitive relaxations of basilar (<bold>F</bold>, n = 7–9), mesenteric (<bold>K</bold>, n = 11–13), and coronary (<bold>O</bold>, n = 7) arteries from RPTPγ KO and WT mice calculated as the difference in relaxations with and without 100 µM L-NAME. For mesenteric and coronary arteries, we applied a concentration of 0.5 and 3.0 µM acetylcholine, respectively. (<bold>G</bold>, <bold>L</bold>, and <bold>P</bold>) Acetylcholine-induced relaxations of basilar (<bold>G</bold>, n = 7–9), mesenteric (<bold>L</bold>, n = 11–13), and coronary (<bold>P</bold>, n = 7) arteries from RPTPγ KO and WT mice after treatment with 100 µM L-NAME, 50 nM apamin, and 1.0 µM TRAM-34. For mesenteric and coronary arteries, we applied a concentration of 0.5 and 3.0 µM acetylcholine, respectively. (<bold>H</bold>) Vascular smooth muscle cell membrane potential responses (ΔV<sub>m</sub>) to 3.0 µM acetylcholine in basilar arteries from RPTPγ KO and WT mice in presence of 100 µM L-NAME. Data were compared using two-way ANOVA followed by Sidak’s post-test (panel <bold>B, C</bold>, and <bold>E-G</bold>), non-parametric Mann-Whitney test (panel <bold>H, K-M</bold>, and <bold>O</bold>), unpaired two-tailed Student’s <italic>t</italic>-test (panel <bold>I</bold> and <bold>J</bold>) or unpaired two-tailed <italic>t</italic>-test with Welch’s correction (panel <bold>N</bold> and <bold>P</bold>). Comparisons in panel <bold>B</bold> and <bold>J</bold> were made after square root transformation. *p&lt;0.05, **p&lt;0.01, NS: not significantly different vs WT.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57553-fig2-v2.tif"/></fig><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>SLIGRL-amide-induced endothelium-dependent vasorelaxation is compromised in basilar, mesenteric, and coronary arteries from RPTPγ KO mice when investigated in presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>.</title><p>(<bold>A</bold> and <bold>D</bold>) Force recordings illustrating SLIGRL-amide-induced vasorelaxation of U46619-contracted basilar arteries under control conditions (<bold>A</bold>) and after treatment with 100 µM L-NAME (<bold>D</bold>). The numbers indicate points of cumulative stepwise increases in SLIGRL-amide from 0.1 µM to 10.0 µM. WO indicates the point of washout. The pre-contraction force development in response to U46619 was normalized in order to display relative relaxations. (<bold>B</bold>, <bold>I</bold>, and <bold>L</bold>) SLIGRL-amide-induced relaxations of basilar (<bold>B</bold>, n = 12), mesenteric (<bold>I</bold>, n = 11), and coronary (<bold>L</bold>, n = 7) arteries from RPTPγ KO and WT mice under control conditions, that is without inhibitors of endothelial function. (<bold>C</bold>) Experiment similar to that in panel B but performed in a CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solution without HEPES (n = 8). (<bold>E</bold>, <bold>J</bold>, <bold>M</bold>) SLIGRL-amide-induced relaxations of basilar (<bold>E</bold>, n = 12), mesenteric (<bold>J</bold>, n = 11), and coronary (<bold>M</bold>, n = 7) arteries from WT and RPTPγ KO mice after treatment with 100 µM L-NAME alone or in combination with 50 nM apamin and 1.0 µM TRAM-34. (<bold>F</bold>, <bold>K</bold>, and <bold>N</bold>) SLIGRL-amide-induced L-NAME-sensitive relaxations of basilar (<bold>F</bold>, n = 12), mesenteric (<bold>K</bold>, n = 11), and coronary (<bold>N</bold>, n = 7) arteries from RPTPγ KO and WT mice calculated as the difference in area under the curve (AUC) between the concentration-response curves with and without L-NAME. (<bold>G</bold> and <bold>H</bold>) Original recordings (<bold>G</bold>) and summarized data (<bold>H</bold>, n = 8–9) from basilar arteries showing vascular smooth muscle cell membrane potential (V<sub>m</sub>) responses to SLIGRL-amide in presence of 100 µM L-NAME. In panel <bold>B, C, E, I, J, L</bold>, and <bold>M</bold>, the relative relaxations were fitted to sigmoidal curves and compared using extra sum-of-squares <italic>F</italic> tests. In panel <bold>F, K</bold>, and <bold>N</bold>, the relative relaxations were compared by unpaired two-tailed Student’s <italic>t</italic>-test. In panel <bold>H</bold>, membrane potential responses were compared by two-way ANOVA followed by Sidak’s post-test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. NS: not significantly different vs WT.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57553-fig3-v2.tif"/></fig><p>Under physiological conditions with CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> present in the buffer solutions, acetylcholine- and SLIGRL-amide-induced vasorelaxation of basilar (<xref ref-type="fig" rid="fig2">Figures 2A–C</xref> and <xref ref-type="fig" rid="fig3">3A–C</xref>), mesenteric (<xref ref-type="fig" rid="fig2">Figures 2I</xref> and <xref ref-type="fig" rid="fig3">3I</xref>), and coronary (<xref ref-type="fig" rid="fig2">Figures 2M</xref> and <xref ref-type="fig" rid="fig3">3L</xref>) arteries from RPTPγ knockout (KO) mice was reduced compared to arteries from wild type (WT) mice. We observed this difference between arteries from RPTPγ KO and WT mice whether experiments in presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> were conducted with (<xref ref-type="fig" rid="fig2">Figures 2B</xref> and <xref ref-type="fig" rid="fig3">3B</xref>) or without (<xref ref-type="fig" rid="fig2">Figures 2C</xref> and <xref ref-type="fig" rid="fig3">3C</xref>) the non-physiological buffer HEPES. Addition of an artificial buffer is necessary for pH control in absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>; and we included HEPES also in the CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solutions in order to separate the vascular effects of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> omission from potential effects of adding HEPES (<xref ref-type="bibr" rid="bib3">Altura et al., 1980</xref>). Acetylcholine-induced vasorelaxation of basilar arteries from RPTPγ KO mice was suppressed in presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> mostly because of attenuated NO-dependent (i.e. <italic>N</italic>-nitro-L-arginine methyl ester (L-NAME)-sensitive) signaling (<xref ref-type="fig" rid="fig2">Figure 2D–G</xref>). In contrast, the diminished vasorelaxation of basilar arteries in response to SLIGRL-amide (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>) and of mesenteric and coronary arteries in response to acetylcholine (<xref ref-type="fig" rid="fig2">Figure 2J–L</xref> and <xref ref-type="fig" rid="fig2">Figure 2N–P</xref>) and SLIGRL-amide (<xref ref-type="fig" rid="fig3">Figure 3J,K,M,N</xref>) was mostly explained by smaller endothelium-dependent hyperpolarization (EDH)-type responses that were L-NAME-insensitive but inhibited by apamin and TRAM-34. Consistent with these findings, L-NAME-insensitive smooth muscle hyperpolarization was significantly attenuated in basilar arteries from RPTPγ KO mice when elicited by SLIGRL-amide (<xref ref-type="fig" rid="fig3">Figure 3G,H</xref>) but not when elicited by acetylcholine (<xref ref-type="fig" rid="fig2">Figure 2H</xref>).</p></sec><sec id="s2-3"><title>The vasorelaxant influence of RPTPγ depends on CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup></title><p>In order to evaluate whether RPTPγ-dependent signaling is influenced by HCO<sub>3</sub><sup>–</sup> in the vascular wall, we next repeated studies of endothelium-dependent vasorelaxation using nominally CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free, HEPES-buffered solutions (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Under these conditions, we saw no RPTPγ-dependent differences in overall vasorelaxant function of basilar or mesenteric arteries in response to acetylcholine (<xref ref-type="fig" rid="fig4">Figure 4A,B,G</xref>) or SLIGRL-amide (<xref ref-type="fig" rid="fig4">Figure 4K,L,P</xref>). The relative contribution of NO-dependent signaling and EDH-type responses to vasorelaxation was also not significantly affected by RPTPγ KO in basilar (<xref ref-type="fig" rid="fig4">Figure 4C–F</xref>) or mesenteric (<xref ref-type="fig" rid="fig4">Figure 4H–J</xref>) arteries in response to acetylcholine. Whereas the dependency on NO-signaling vs EDH-type vasorelaxation in response to SLIGRL-amide was likewise not affected in mesenteric arteries (<xref ref-type="fig" rid="fig4">Figure 4Q,R</xref>), we saw indications of an apparent relative increase in NO-mediated vasorelaxation when basilar arteries from RPTPγ KO mice were stimulated with SLIGRL-amide in absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> (<xref ref-type="fig" rid="fig4">Figure 4M–O</xref>). This unexpected change in the relative importance of the underlying vasorelaxant mechanisms in basilar arteries could be a compensation secondary to the predominant inhibition of NO-dependent vasorelaxation in these arteries in presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> (<xref ref-type="fig" rid="fig2">Figure 2F</xref>) and hence presumably in vivo.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>In absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>, acetylcholine (ACh)- and SLIGRL-amide-induced endothelium-dependent vasorelaxation of basilar and mesenteric arteries is similar between RPTPγ KO and WT mice.</title><p>(<bold>A</bold> and <bold>C</bold>) Force recordings illustrating acetylcholine-induced vasorelaxation of U46619-contracted basilar arteries under control conditions (<bold>A</bold>) and after treatment with 100 µM L-NAME (<bold>C</bold>). The pre-contraction force development in response to U46619 was normalized in order to display relative relaxations. (<bold>B</bold> and <bold>G</bold>) Acetylcholine-induced relaxations of basilar (<bold>B</bold>, n = 11) and mesenteric (<bold>G</bold>, n = 6–7) arteries from RPTPγ KO and WT mice under control CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free conditions, that is, without inhibitors of endothelial function. (<bold>D</bold> and <bold>H</bold>) Acetylcholine-induced relaxations of basilar (<bold>D</bold>, n = 11) and mesenteric (<bold>H</bold>, n = 6–7) arteries from RPTPγ KO and WT mice in presence of 100 µM L-NAME under CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free conditions. (<bold>E</bold> and <bold>I</bold>) Acetylcholine-induced L-NAME-sensitive relaxations of basilar (<bold>E</bold>, n = 11) and mesenteric (<bold>I</bold>, n = 6–7) arteries from RPTPγ KO and WT mice calculated as the difference between relaxations with and without L-NAME. Experiments were performed in absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>. (<bold>F</bold> and <bold>J</bold>) Acetylcholine-induced relaxations of basilar (<bold>F</bold>, n = 11) and mesenteric (<bold>J</bold>, n = 6–7) arteries from RPTPγ KO and WT mice after treatment with 100 µM L-NAME, 50 nM apamin, and 1.0 µM TRAM-34 under CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free conditions. (<bold>K</bold> and <bold>M</bold>) Force recordings illustrating SLIGRL-amide-induced vasorelaxation of U46619-contracted basilar arteries under control conditions (<bold>K</bold>) and after treatment with 100 µM L-NAME (<bold>M</bold>). The numbers indicate points of cumulative stepwise increases in SLIGRL-amide from 0.1 µM to 10.0 µM. WO indicates the point of washout. The pre-contraction force development in response to U46619 was normalized in order to display relative relaxations. (<bold>L</bold> and <bold>P</bold>) SLIGRL-amide-induced relaxations of basilar (<bold>L</bold>, n = 10) and mesenteric (<bold>P</bold>, n = 6–7) arteries from RPTPγ KO and WT mice under control CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free conditions, that is, without inhibitors of endothelial function. (<bold>N</bold> and <bold>Q</bold>) SLIGRL-amide-induced relaxations of basilar (<bold>N</bold>, n = 10) and mesenteric (<bold>Q</bold>, n = 6–7) arteries from RPTPγ KO and WT mice after treatment with 100 µM L-NAME alone or in combination with 50 nM apamin and 1.0 µM TRAM-34. The experiments were performed in absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>. (<bold>O</bold> and <bold>R</bold>) SLIGRL-amide-induced L-NAME-sensitive relaxations of basilar (<bold>O</bold>, n = 10) and mesenteric (<bold>R</bold>, n = 6–7) arteries from RPTPγ KO and WT mice calculated as the difference in area under the curve (AUC) between the concentration-response curves with and without L-NAME. In panels <bold>A-J</bold>, we applied a concentration of 0.5 µM acetylcholine. Data in panels <bold>B, E, G-J</bold>, and <bold>O</bold> were compared by unpaired two-tailed Student’s <italic>t</italic>-tests, data in panels <bold>D</bold> and R by non-parametric Mann-Whitney test, and data in panel <bold>F</bold> by unpaired two-tailed <italic>t</italic>-test with Welch’s correction. In panels <bold>L, N, P</bold>, and <bold>Q</bold>, the relative relaxations were fitted to sigmoidal curves and compared using extra sum-of-squares <italic>F</italic> tests. Data in panel <bold>J</bold> were log-transformed before comparison. **p&lt;0.01, NS: not significantly different vs WT.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57553-fig4-v2.tif"/></fig></sec><sec id="s2-4"><title>NO-synthase expression and responses to NO donors are largely independent of RPTPγ</title><p>We next explored the mechanism whereby RPTPγ influences resistance artery function (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Acetylcholine (ACh)-induced endothelial intracellular Ca<sup>2+</sup> responses are lower in arteries from RPTPγ KO than WT mice.</title><p>In contrast, expression of endothelial NO-synthase (eNOS), responses to NO-donors, and endothelial intracellular pH are unaffected in basilar and mesenteric arteries from RPTPγ KO compared to WT mice. (<bold>A</bold> and <bold>D</bold>). Expression of eNOS in basilar (<bold>A</bold>) and mesenteric (<bold>D</bold>) arteries from RPTPγ KO and WT mice (n = 5–6). Representative bands are shown next to results from densitometric analyses where the expression levels relative to pan-actin are normalized to the average level in arteries from WT mice. (<bold>B</bold> and <bold>E</bold>) Spermine NONOate-induced relaxations of basilar (<bold>B</bold>, n = 10–14) and mesenteric (<bold>E</bold>, n = 9) arteries from RPTPγ KO and WT mice. (<bold>C</bold> and <bold>F</bold>) SNAP-induced relaxations of basilar (<bold>C</bold>, n = 10–15) and mesenteric (<bold>F</bold>, n = 9) arteries from RPTPγ KO and WT mice. All experiments in panels <bold>B, C, E</bold>, and <bold>F</bold> were performed on arteries pre-contracted with U46619, in presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>, and after treatment with 100 µM L-NAME, 50 nM apamin, and 1.0 µM TRAM-34. (<bold>G</bold> and <bold>K</bold>) Overlaid fluorescence images of endothelial cells in basilar (<bold>G</bold>) and mesenteric (<bold>K</bold>) arteries loaded by luminal perfusion with Fluo-4 (green) and Fura Red (red). (<bold>H</bold>, <bold>I</bold>, <bold>L</bold>, and <bold>M</bold>) Average traces of acetylcholine-induced endothelial intracellular Ca<sup>2+</sup> responses in basilar (<bold>H</bold> and <bold>I</bold>) and mesenteric (<bold>L</bold> and <bold>M</bold>) arteries from RPTPγ KO and WT mice (n = 6–9) in presence (<bold>H</bold> and <bold>L</bold>) and absence (<bold>I</bold> and <bold>M</bold>) of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>. The evaluation of endothelial Ca<sup>2+</sup> responses was based on the <italic>F</italic><sub>505-530</sub>/<italic>F</italic><sub>&gt;600</sub> ratio normalized to the average ratio during the first two minutes of the individual recordings. (<bold>J</bold> and <bold>N</bold>) Summarized endothelial intracellular Ca<sup>2+</sup> responses in basilar (<bold>J</bold>) and mesenteric (<bold>N</bold>) arteries upon acetylcholine stimulation (n = 6–9). The endothelial Ca<sup>2+</sup> response was calculated as the average increase in normalized fluorescence during the 2 min acetylcholine exposure compared to the baseline value before activation. (<bold>O</bold>) Schematic illustration of how RPTPγ influences vasomotor functions of resistance arteries. (<bold>P</bold> and <bold>Q</bold>) Steady-state intracellular pH of endothelial cells in basilar (<bold>P</bold>) and mesenteric (<bold>Q</bold>) arteries from RPTPγ KO and WT mice (n = 5–7) in the presence and absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>. In panels <bold>A</bold> and <bold>D</bold>, expression levels were compared with unpaired two-tailed Student’s <italic>t</italic>-tests. In panels <bold>B, C, E</bold>, and <bold>F</bold>, the relative relaxations were fitted to sigmoidal curves and compared using extra sum-of-squares <italic>F</italic> tests. In panels <bold>J</bold> and <bold>N</bold>, data were compared by two-way ANOVA followed by Sidak’s post-tests. In panels <bold>P</bold> and <bold>Q</bold>, data were compared by repeated-measures two-way ANOVA followed by Sidak’s post-tests. The data in panel <bold>N</bold> were log-transformed before comparisons. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, NS: not significantly different vs WT. ER, endoplasmic reticulum; K<sub>ir</sub>, inward-rectifier K<sup>+</sup>-channel; IK<sub>Ca</sub>, intermediate-conductance K<sup>+</sup>-channel; NOS, NO-synthase; SK<sub>Ca</sub>, small-conductance K<sup>+</sup>-channel; SNAP, <italic>S</italic>-nitroso-<italic>N</italic>-acetylpenicillamine.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57553-fig5-v2.tif"/></fig><p>We first evaluated whether the difference in vasorelaxation between arteries from RPTPγ KO and WT mice depends on a change in expression of the endothelial NO-synthase (eNOS). Based on immunoblotting of basilar (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) and mesenteric (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) arteries, we found equal eNOS expression between arteries from RPTPγ KO and WT mice.</p><p>We also evaluated whether the smooth muscle vasorelaxant responses to exogenous NO differ between arteries from WT and RPTPγ KO mice. In presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>, spermine NONOate and <italic>S</italic>-nitroso-<italic>N</italic>-acetylpenicillamine (SNAP) produced equivalent vasorelaxation in basilar and mesenteric arteries from RPTPγ KO and WT mice (<xref ref-type="fig" rid="fig5">Figure 5B,C,E,F</xref>).</p><p>Together, our findings support that RPTPγ exerts acute influences on endothelial signaling pathways regulating the activity of endothelium-dependent vasorelaxation in response to [HCO<sub>3</sub><sup>–</sup>]. This interpretation is in agreement with the near-complete normalization of vasorelaxation observed in arteries from RPTPγ KO mice upon omission of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s2-5"><title>RPTPγ enhances endothelial Ca<sup>2+</sup> responses with no effect on intracellular pH</title><p>We then determined whether endothelial intracellular Ca<sup>2+</sup> signals differ between arteries from RPTPγ KO and WT mice (<xref ref-type="fig" rid="fig5">Figure 5G–N</xref>). Loading of isolated arteries with Ca<sup>2+</sup>-sensitive fluorophores through luminal perfusion ensured endothelium-specific fluorescence signals (<xref ref-type="fig" rid="fig5">Figure 5G,K</xref>).</p><p>In the presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>, application of acetylcholine elevated intracellular [Ca<sup>2+</sup>] substantially more in endothelial cells of basilar and mesenteric arteries from WT mice than in arteries from RPTPγ KO mice (<xref ref-type="fig" rid="fig5">Figure 5H,J,L,N</xref>). In contrast, we saw no significant difference between the intracellular Ca<sup>2+</sup> responses of endothelial cells in arteries from WT and RPTPγ KO mice when they were investigated in the nominal absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> (<xref ref-type="fig" rid="fig5">Figure 5I,J,M,N</xref>).</p><p>Reduced endothelial intracellular Ca<sup>2+</sup> responses in arteries from RPTPγ KO mice in presence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> likely explain the observed mixed attenuation of NO-mediated and EDH-type vasorelaxation (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>) as these responses rely on the Ca<sup>2+</sup>-sensitive NO-synthase and on intermediate- (IK<sub>Ca</sub>) and small-conductance (SK<sub>Ca</sub>) Ca<sup>2+</sup>-activated K<sup>+</sup>-channels, respectively (<xref ref-type="fig" rid="fig5">Figure 5O</xref>).</p><p>Intracellular H<sup>+</sup> and Ca<sup>2+</sup> can compete for buffer binding (<xref ref-type="bibr" rid="bib8">Batlle et al., 1993</xref>), many Ca<sup>2+</sup> handling proteins are pH-sensitive (<xref ref-type="bibr" rid="bib19">Boedtkjer and Aalkjaer, 2012</xref>), and pH is an important regulator of NO-synthase activity (<xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>). Therefore, we next evaluated whether RPTPγ KO influences intracellular pH—measured using the pH-sensitive fluorophore BCECF—in endothelial cells of small arteries. In basilar (<xref ref-type="fig" rid="fig5">Figure 5P</xref>) as well as mesenteric (<xref ref-type="fig" rid="fig5">Figure 5Q</xref>) arteries, intracellular pH of the endothelial cells was similar for RPTPγ KO and WT mice, irrespective of whether experiments were performed with or without CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>. Omission of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> from the bath solutions had no net effect on endothelial steady-state intracellular pH (<xref ref-type="fig" rid="fig5">Figure 5P,Q</xref>), which is consistent with previous studies based on arteries from C57BL/6 mice (<xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Boedtkjer et al., 2012</xref>).</p></sec><sec id="s2-6"><title>RPTPγ amplifies hyperventilation-induced blood pressure elevations</title><p>If the vasomotor impact of RPTPγ is sufficiently widespread to affect total peripheral resistance, we predicted that KO of RPTPγ would influence blood pressure regulation. We therefore measured systemic blood pressure and heart rate by radiotelemetry (<xref ref-type="fig" rid="fig6">Figure 6A,B</xref>). Based on these recordings, we observed no difference in resting blood pressure or heart rate (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) or in the blood pressure-elevating effect of L-NAME (<xref ref-type="fig" rid="fig6">Figure 6B</xref>) between RPTPγ KO and WT mice.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Systemic blood pressure and heart rate are similar in WT and RPTPγ KO mice at rest.</title><p>In contrast, RPTPγ KO mice show elevated cerebrovascular perfusion during whisker stimulation, attenuated hyperventilation-induced blood pressure elevation, and diminished hyperventilation-induced reduction in cerebrovascular perfusion. (<bold>A</bold>) Resting mean arterial pressure (MAP) and heart rate (HR) measured by radiotelemetry in WT and RPTPγ KO mice (n = 6–7). Data were compared by unpaired two-tailed Student’s <italic>t</italic>-tests. (<bold>B</bold>) Mean arterial pressure under control conditions and during intake of 100 and 600 mg/kg/day L-NAME in the drinking water (n = 4–5). Data were square root-transformed and then compared by repeated-measures two-way ANOVA. (<bold>C</bold>) Changes in relative mean arterial blood pressure (ΔMAP, solid lines) and expiratory end-tidal CO<sub>2</sub> fraction (F<sub>ET</sub>CO<sub>2</sub>, dashed lines) during hyperventilation (n = 13). The steady-state values averaged over the last 30 s of the stimulation period were compared between WT and RPTPγ KO mice by unpaired two-tailed Student’s <italic>t</italic>-test (ΔMAP) or non-parametric Mann-Whitney test (F<sub>ET</sub>CO<sub>2</sub>). In the anesthetized mice, the absolute mean arterial blood pressure prior to hyperventilation was 63 ± 5 mmHg in RPTPγ KO compared to 60 ± 3 mmHg in WT mice (p=0.63, unpaired two-tailed Student’s <italic>t</italic>-test). (<bold>D</bold>) Exemplar laser speckle images. The left image shows the second posterior bifurcation of the middle cerebral artery (arrows) that was used to locate the same region of interest (dotted square) in each experiment. The right image provides a 7.5% threshold response map from a whisker stimulation experiment in an RPTPγ KO mouse. (<bold>E</bold> and <bold>F</bold>) Relative cerebrovascular perfusion in the barrel cortex (dotted square in panel D) of RPTPγ KO and WT mice during whisker stimulation (<bold>E</bold>, n = 9) and during hyperventilation alone or combined with whisker stimulation (<bold>F</bold>, n = 8). The steady-state blood flow index averaged over the last minute of the intervention period was compared between WT and RPTPγ KO mice by unpaired two-tailed Student’s <italic>t</italic>-test (whisker stimulation) or unpaired two-tailed <italic>t</italic>-test with Welch’s correction (hyperventilation). *p&lt;0.05, **p&lt;0.01, NS: not significantly different vs WT. F<sub>ET</sub>CO<sub>2</sub> indicates the expiratory end-tidal CO<sub>2</sub> fraction measured by capnography.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57553-fig6-v2.tif"/></fig><p>As the lack of difference in resting blood pressure between WT and RPTPγ mice could be due to compensatory adaptations, we next studied acute blood pressure responses of endotracheally intubated, mechanically ventilated mice under capnographic control. When mice were ventilated to a normal expiratory end-tidal CO<sub>2</sub> fraction (F<sub>ET</sub>CO<sub>2</sub>) of 3.5%, arterial blood gas parameters were very similar in RPTPγ KO and WT mice (<xref ref-type="table" rid="table1">Table 1</xref>) consistent with previous findings (<xref ref-type="bibr" rid="bib55">Zhou et al., 2016</xref>). Hyperventilating mice until F<sub>ET</sub>CO<sub>2</sub> was lowered to 2% caused the expected decrease in P<sub>a</sub>CO<sub>2</sub> and increase in pH<sub>a</sub> (<xref ref-type="table" rid="table1">Table 1</xref>). The shift of the chemical equilibrium <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mo stretchy="false">⇄</mml:mo><mml:mi mathvariant="normal">H</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mrow><mml:msub><mml:mi/><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mi/><mml:mo>−</mml:mo></mml:msup></mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="normal">H</mml:mi><mml:mrow><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> also resulted in the anticipated decrease in [HCO<sub>3</sub><sup>–</sup>]<sub>a</sub> (<xref ref-type="table" rid="table1">Table 1</xref>). The mean arterial blood pressure of WT mice increased around 20% during hyperventilation and this blood pressure response was reduced by approximately 1/3 in RPTPγ KO mice (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Although the observed hyperventilation-induced reduction in arterial [HCO<sub>3</sub><sup>–</sup>] was of modest magnitude (1.4 mM, <xref ref-type="table" rid="table1">Table 1</xref>), the associated increase in blood pressure is consistent with attenuated RPTPγ-dependent vasodilator influences when extracellular [HCO<sub>3</sub><sup>–</sup>] decreases (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>). The remaining hyperventilation-induced blood pressure elevation likely results from a direct vasocontractile effect of alkalosis (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Arterial blood gas measurements from RPTPγ KO and WT mice (n = 7–9) under control conditions (normoventilation, F<sub>ET</sub>CO<sub>2</sub> = 3.5%) and after 2 min of hyperventilation (F<sub>ET</sub>CO<sub>2</sub> = 2%).</title><p>We compared data by repeated-measures two-way ANOVA. F<sub>ET</sub>CO<sub>2</sub>, expiratory end-tidal CO<sub>2</sub> fraction.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Arterial blood gasses</th><th colspan="2" valign="top">WT</th><th colspan="2" valign="top">RPTPγ KO</th></tr></thead><tbody><tr><td colspan="5" valign="top"><italic>Control</italic>, F<sub>ET</sub>CO<sub>2</sub> = 3.5%</td></tr><tr><td valign="top">pH<sub>a</sub></td><td colspan="2" valign="top">7.28 ± 0.01</td><td colspan="2" valign="top">7.28 ± 0.01</td></tr><tr><td valign="top">P<sub>a</sub>CO<sub>2</sub> (mmHg)</td><td colspan="2" valign="top">45.2 ± 1.2</td><td colspan="2" valign="top">46.2 ± 1.8</td></tr><tr><td valign="top">[HCO<sub>3</sub><sup>–</sup>]<sub>a</sub> (mM)</td><td colspan="2" valign="top">20.4 ± 0.6</td><td colspan="2" valign="top">20.9 ± 0.8</td></tr><tr><td colspan="5" valign="top"><italic>Hyperventilation</italic>, F<sub>ET</sub>CO<sub>2</sub> = 2%</td></tr><tr><td valign="top">pH<sub>a</sub></td><td colspan="2" valign="top">7.38 ± 0.02</td><td colspan="2" valign="top">7.41 ± 0.01</td></tr><tr><td valign="top">P<sub>a</sub>CO<sub>2</sub> (mmHg)</td><td colspan="2" valign="top">32.3 ± 0.9</td><td colspan="2" valign="top">32.3 ± 1.5</td></tr><tr><td valign="top">[HCO<sub>3</sub><sup>–</sup>]<sub>a</sub> (mM)</td><td colspan="2" valign="top">19.0 ± 0.9</td><td colspan="2" valign="top">19.2 ± 0.8</td></tr><tr><td valign="top">Statistics (repeated-measures two-way ANOVA)</td><td colspan="4" valign="top">p-Values</td></tr><tr><td valign="top"/><td valign="top">Genotype</td><td colspan="2" valign="top">Ventilation</td><td valign="top">Interaction</td></tr><tr><td valign="top">pH<sub>a</sub></td><td valign="top">0.40</td><td colspan="2" valign="top">&lt;0.001</td><td valign="top">0.19</td></tr><tr><td valign="top">P<sub>a</sub>CO<sub>2</sub></td><td valign="top">0.90</td><td colspan="2" valign="top">&lt;0.001</td><td valign="top">0.06</td></tr><tr><td valign="top">[HCO<sub>3</sub><sup>–</sup>]<sub>a</sub></td><td valign="top">0.69</td><td colspan="2" valign="top">&lt;0.001</td><td valign="top">0.47</td></tr></tbody></table></table-wrap></sec><sec id="s2-7"><title>RPTPγ regulates cerebral perfusion</title><p>Metabolic waste products—that are generated at elevated rate and locally accumulate when neuronal activity increases—influence cerebral blood flow. We studied cerebral perfusion using laser speckle imaging (<xref ref-type="fig" rid="fig6">Figure 6D–F</xref>) in order to evaluate the involvement of RPTPγ in sensing of acid-base disturbances. Tissue perfusion in the somatosensory barrel cortex increased twice as much in RPTPγ KO mice compared to WT mice during whisker stimulation (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). This finding is consistent with metabolically produced H<sup>+</sup> leading to a local decrease in [HCO<sub>3</sub><sup>–</sup>] that is sensed via RPTPγ in arteries from WT mice (<xref ref-type="fig" rid="fig5">Figure 5O</xref>). As RPTPγ-dependent vasorelaxation wanes at low [HCO<sub>3</sub><sup>–</sup>] (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>), our data support that RPTPγ limits increases in cerebral perfusion induced by metabolic acidosis (<xref ref-type="fig" rid="fig6">Figure 6E</xref>).</p><p>Acid-base conditions during increased neuronal activity are complicated, as the increased metabolism will also induce some degree of CO<sub>2</sub> accumulation that tends to increase [HCO<sub>3</sub><sup>–</sup>]. In order to produce a simpler acid-base disturbance with predictable changes in extracellular [HCO<sub>3</sub><sup>–</sup>], we next hyperventilated mice, which reduced pCO<sub>2</sub>, increased pH, and lowered [HCO<sub>3</sub><sup>–</sup>] (<xref ref-type="table" rid="table1">Table 1</xref>). Under these conditions, cerebral vasoconstriction is expected in WT mice based on the combined effect of alkalosis and decreased [HCO<sub>3</sub><sup>–</sup>] (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>). If RPTPγ is required for sensing of HCO<sub>3</sub><sup>–</sup>, only the effect of the elevated pH is expected in the RPTPγ KO mice; and indeed, we saw a 30% smaller drop in cerebral perfusion in RPTPγ KO mice compared to WT mice during hyperventilation (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). These recordings may in fact underestimate the difference in cerebrovascular resistance between RPTPγ KO and WT mice since the cerebral perfusion pressure—based on the blood pressure changes shown in (<xref ref-type="fig" rid="fig6">Figure 6C</xref>)—increased less in hyperventilated RPTPγ KO than WT mice. When whisker stimulation was performed during hyperventilation, we saw an even more prominent difference in cerebral perfusion between WT and RPTPγ KO mice (<xref ref-type="fig" rid="fig6">Figure 6F</xref>).</p><p>Together, our findings demonstrate that RPTPγ plays a substantial role for control of blood pressure (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) and cerebral perfusion (<xref ref-type="fig" rid="fig6">Figure 6E,F</xref>) during acid-base deviations where [HCO<sub>3</sub><sup>–</sup>] decreases below the normal level.</p></sec><sec id="s2-8"><title><italic>PTPRG</italic> is a susceptibility locus for ischemic vascular disease</title><p>Based on human exome sequencing data from the UK Biobank, we next explored whether the functional role of RPTPγ in regulating endothelial function and responding to metabolic disturbances in murine cerebral, mesenteric, and coronary arteries is corroborated by and translates to an altered risk for human ischemic vascular disease amongst carriers of predicted loss-of-function variants within <italic>PTPRG</italic>. We identified 334 missense variants and 75 predicted loss-of-function variants (categorized as low, moderate, and high impact) in <italic>PTPRG</italic> among the ~50,000 UK Biobank participants with available exome sequencing data.</p><p>The 72 carriers of predicted loss-of-function <italic>PTPRG</italic> variants with moderate or high impact showed substantially elevated risk (<xref ref-type="fig" rid="fig7">Figure 7A</xref>) of a combined vascular disease phenotype encompassing the three vascular beds functionally investigated in this study (<xref ref-type="fig" rid="fig2">Figures 2</xref>–<xref ref-type="fig" rid="fig6">6</xref>): cerebral infarct (ICD-10 diagnosis code I63), angina pectoris (ICD-10 diagnosis code I20), acute myocardial infarction (ICD-10 diagnosis code I21), and acute vascular disorders of the intestine (ICD-10 diagnosis code K55.0). In contrast, the 123 carriers of predicted loss-of-function <italic>PTPRG</italic> variants with low impact as well as the 29,975 carriers of one or more missense <italic>PTPRG</italic> variants had a risk similar to non-carriers for this aggregated phenotype of acute vascular disease (<xref ref-type="fig" rid="fig7">Figure 7A</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Burden analysis of loss-of-function variants in <italic>PTPRG</italic> reveals association with human ischemic vascular disease.</title><p>(<bold>A</bold>) Association of <italic>PTPRG</italic> missense variants (localized outside exon-intron boundary regions) and predicted loss-of-function (LOF) variants of low, moderate, and high impact with ischemic cerebral, coronary, and mesenteric vascular disease (aggregate of ICD-10 diagnosis codes I20, I21, I63, and K55.0). (<bold>B</bold> and <bold>C</bold>) Association of predicted moderate- and high-impact loss-of-function variants in <italic>PTPRG</italic> with diagnosed (<bold>B</bold>) and self-reported (<bold>C</bold>) coronary and cerebral ischemia. (<bold>D</bold>) Association between missense and loss-of-function variants in <italic>PTPRG</italic> and left ventricular ejection fraction. The p-values in panel <bold>A</bold> through <bold>C</bold> come from logistic regression analyses and the p-values in panel <bold>D</bold> from multiple linear regression analyses. In each case, we adjusted for sex, age, body mass index, genetic principal component, smoking status, dyslipidemia, diabetes, and hypertension.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57553-fig7-v2.tif"/></fig><p>We followed-up by investigating the separate occurrences of diagnosed angina pectoris, acute myocardial infarction, and cerebral infarction amongst the individuals, who carried a predicted loss-of-function variant with moderate or high impact. The carriers of these most severe loss-of-function variants had dramatically increased risk (~7 fold) of cerebral infarction whereas the risk of acute myocardial infarction showed a tendency toward elevation that did not reach statistical significance (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). The number of exome-sequenced UK Biobank participants with acute intestinal vascular disease was too low to provide statistical power for a separate analysis.</p><p>To complement the evidence based on ICD-10 diagnosis codes, we further evaluated whether carriers of missense and loss-of-function variants in <italic>PTPRG</italic> differed in self-reported diseases compared to non-carriers (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). The risk of self-reported heart attacks was greatly elevated (~4 fold) amongst individuals carrying loss-of-function <italic>PTPRG</italic> variants of moderate and high impact (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). The risk of self-reported stroke also showed a strong tendency toward elevation—with borderline statistical significance—amongst the carriers of moderate- and high-impact loss-of-function <italic>PTPRG</italic> variants (<xref ref-type="fig" rid="fig7">Figure 7C</xref>).</p><p>As cardiac pumping function often deteriorates following coronary ischemia, we next evaluated the cardiac contractile function in <italic>PTPRG</italic> loss-of-function carriers amongst the 12,851 exome-sequenced UK Biobank participants with available cardiac magnetic resonance imaging (MRI) data. We observed a significantly lower left ventricular ejection fraction in carriers of high-impact loss-of-function <italic>PTPRG</italic> variants compared to non-carriers (<xref ref-type="fig" rid="fig7">Figure 7D</xref>) consistent with the greater risk of ischemic heart disease (<xref ref-type="fig" rid="fig7">Figure 7C</xref>).</p><p>The statistical analyses linking <italic>PTPRG</italic> to risk of ischemic vascular disease (<xref ref-type="fig" rid="fig7">Figure 7A–C</xref>) and reduced left ventricular ejection fraction (<xref ref-type="fig" rid="fig7">Figure 7D</xref>) were all adjusted for sex, age, body mass index, genetic principal component, smoking status, dyslipidemia, diabetes, and hypertension between carriers and non-carriers of the evaluated <italic>PTPRG</italic> variants.</p><p>Taken together, we demonstrate that RPTPγ (a) CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-dependently enhances endothelial intracellular Ca<sup>2+</sup> responses and endothelium-dependent vasorelaxation, (b) regulates microvascular perfusion and blood pressure during acid-base disturbances, and (c) is associated with human ischemic vascular disease of the brain and heart.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Local acid-base-dependent mechanisms of arterial tone regulation match tissue perfusion to the oxidative metabolic demand and thereby dynamically control cardiovascular function during cycles of intermittent rest and activity. Re-establishing proper tissue perfusion is of obvious clinical importance when managing patients with latent or fulminant ischemia. Responses of coronary and cerebral arteries to acid-base disturbances have been recognized for almost 140 years (<xref ref-type="bibr" rid="bib30">Gaskell, 1880</xref>; <xref ref-type="bibr" rid="bib33">Lassen, 1968</xref>) but this information has not yet been harnessed for therapeutic intervention for lack of identified molecular players and their interactions. In the current study, we identify <italic>PTPRG</italic> as a susceptibility locus for human ischemic vascular disease (<xref ref-type="fig" rid="fig7">Figure 7</xref>) and provide mechanistic evidence that RPTPγ regulates endothelial intracellular Ca<sup>2+</sup> responses (<xref ref-type="fig" rid="fig5">Figure 5H,L</xref>), endothelium-dependent vasorelaxation (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>), cerebral perfusion (<xref ref-type="fig" rid="fig6">Figure 6E,F</xref>), and blood pressure (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) during acid-base disturbances and increased metabolic demand.</p><p>Variation in buffer composition accompanies changes in pH during acid-base disturbances. We show that the CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> buffer plays a hitherto unappreciated role for regulation of endothelial function and arterial tone through mechanisms that require RPTPγ (<xref ref-type="fig" rid="fig2">Figures 2</xref>–<xref ref-type="fig" rid="fig4">4</xref>). As schematically illustrated in <xref ref-type="fig" rid="fig5">Figure 5O</xref>, we demonstrate that RPTPγ enhances endothelial intracellular Ca<sup>2+</sup> signals (<xref ref-type="fig" rid="fig5">Figure 5G–N</xref>) that in turn activate endothelial NO synthesis and EDH-type responses (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>). These effects are in congruence with the Ca<sup>2+</sup>-sensitivity of eNOS and the SK and IK Ca<sup>2+</sup>-activated K<sup>+</sup>-channels. The vasorelaxant influence of RPTPγ wanes at low extracellular [HCO<sub>3</sub><sup>–</sup>] (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>), which attenuates by half the elevation of cerebral perfusion during sensory input (<xref ref-type="fig" rid="fig6">Figure 6E</xref>) and amplifies by 30% the decrease in perfusion during hyperventilation (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). We also observe that RPTPγ is necessary for approximately 1/3 of the blood pressure increase during hyperventilation (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig6">Figure 6C</xref>). Considering the prominent influence of RPTPγ on endothelial function in several vascular beds, somewhat surprisingly, we observe blood pressure consequences of RPTPγ KO only when we impose acute acid-base disturbances (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>). The unaltered resting blood pressure in RPTPγ KO mice (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) most likely reflects that numerous discrete mechanisms are involved in blood pressure control and that compensation—for example, through nervous, hormonal or renal influences (<xref ref-type="bibr" rid="bib21">Boedtkjer and Aalkjaer, 2013b</xref>)—can maintain blood pressure in the sustained phase and mask hemodynamic consequences of RPTPγ except when acute acid-base disturbances are imposed.</p><p>Previously recognized cellular acid-base sensors include G-protein coupled receptors (e.g. OGR1, GPR4, and TDAG8), ion channels (e.g. ASIC, BK<sub>Ca</sub>), and enzymes (e.g. NO-synthase and rho-kinase) sensitive to H<sup>+</sup> (<xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Boedtkjer et al., 2012</xref>; <xref ref-type="bibr" rid="bib29">Fleming et al., 1994</xref>; <xref ref-type="bibr" rid="bib43">Schubert et al., 2001</xref>; <xref ref-type="bibr" rid="bib35">Ludwig et al., 2003</xref>; <xref ref-type="bibr" rid="bib52">Wemmie et al., 2006</xref>; <xref ref-type="bibr" rid="bib53">Wenzel et al., 2020</xref>). In addition, we and others have described cellular functions responsive to changes in [HCO<sub>3</sub><sup>–</sup>] and modified by RPTPγ (<xref ref-type="bibr" rid="bib55">Zhou et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>) or the soluble adenylyl cyclase (<xref ref-type="bibr" rid="bib26">Chen et al., 2000</xref>). Evidence connecting acid-base sensors to human disease has so far been scarce; but in the current study, we identify <italic>PTPRG</italic> as an ischemia susceptibility locus (<xref ref-type="fig" rid="fig7">Figure 7</xref>), which is supported by a recent meta-analysis of genome-wide association studies linking <italic>PTPRG</italic> to ischemic stroke in African Americans (<xref ref-type="bibr" rid="bib25">Carty et al., 2015</xref>).</p><p>Using out-of-equilibrium technology—that permits separate control of pH and the individual CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> buffer components—we previously demonstrated that RPTPγ responds to changes in extracellular [HCO<sub>3</sub><sup>–</sup>] independently of pCO<sub>2</sub> and pH (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>). The homology between the extracellular domain of RPTPγ and the active site of the carbonic anhydrases supports the ability of RPTPγ to bind HCO<sub>3</sub><sup>–</sup> even though it lacks histidine residues required for carbonic anhydrase activity (<xref ref-type="bibr" rid="bib55">Zhou et al., 2016</xref>). The intracellular aspect of RPTPγ contains phosphatase domains with suggested auto-inhibitory activity; and HCO<sub>3</sub><sup>–</sup> possibly alters the phosphatase activity by influencing the degree of RPTPγ dimerization (<xref ref-type="bibr" rid="bib7">Barr et al., 2009</xref>). The separate signaling effects of H<sup>+</sup> and HCO<sub>3</sub><sup>–</sup> are further confirmed by the similar steady-state intracellular pH of endothelial cells in arteries from WT and RPTPγ KO mice (<xref ref-type="fig" rid="fig5">Figure 5P,Q</xref>).</p><p>The current study adds to our growing appreciation that acid-base equivalents, and HCO<sub>3</sub><sup>–</sup> in particular, fulfill multifaceted functions (<xref ref-type="bibr" rid="bib14">Boedtkjer et al., 2016a</xref>). In cerebral resistance arteries, HCO<sub>3</sub><sup>–</sup> (a) contributes to buffering of acute acid loads (<xref ref-type="bibr" rid="bib39">Rasmussen and Boedtkjer, 2018</xref>), (b) serves as substrate particularly for the Na<sup>+</sup>,HCO<sub>3</sub><sup>–</sup>-cotransporter NBCn1 that protects against intracellular acidification (<xref ref-type="bibr" rid="bib46">Thomsen et al., 2014</xref>), and (c) is sensed by RPTPγ to regulate cerebral perfusion (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In migrating vascular smooth muscle cells from conduit arteries, the high spatial mobility of the CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> buffer system also contributes to dissipating local pH gradients in diffusion-restricted spaces of filopodia (<xref ref-type="bibr" rid="bib15">Boedtkjer et al., 2016b</xref>).</p><p>Our current (<xref ref-type="fig" rid="fig1">Figures 1</xref>–<xref ref-type="fig" rid="fig4">4</xref> and <xref ref-type="fig" rid="fig6">6</xref>) and previous (<xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>) findings demonstrate that the endothelium of resistance arteries senses the local acid-base composition and has capacity to modify vascular resistance and perfusion in response to disturbances in extracellular [HCO<sub>3</sub><sup>–</sup>]. Earlier studies of mouse arteries provide additional evidence that intracellular acidification inhibits endothelial NO-synthesis (<xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Boedtkjer et al., 2012</xref>; <xref ref-type="bibr" rid="bib46">Thomsen et al., 2014</xref>), intracellular alkalinisation interferes with myo-endothelial current transfer required for EDH-type responses (<xref ref-type="bibr" rid="bib13">Boedtkjer et al., 2013a</xref>), and acid-base disturbances modify prostanoid-mediated endothelium-dependent vasocontraction (<xref ref-type="bibr" rid="bib5">Baretella et al., 2014</xref>). Together, these studies highlight the sophisticated nature of vasomotor control that integrate the requirement for local blood flow and the necessity to minimize deviations in capillary pressure and fluid filtration during local metabolic disturbances, perturbed nutrient delivery, and restricted waste product elimination. Acting as a brake on vasodilation in regions of unmet metabolic demand, RPTPγ could reduce the degree of edema and consequent tissue damage caused by unopposed H<sup>+</sup>-induced vasodilation (<xref ref-type="bibr" rid="bib17">Boedtkjer, 2018</xref>; <xref ref-type="bibr" rid="bib14">Boedtkjer et al., 2016a</xref>).</p><p>As illustrated in <xref ref-type="fig" rid="fig1">Figure 1D and E</xref>, <italic>Ptprg</italic> mRNA is found in arteriolar, capillary, as well as venular endothelial cells (<xref ref-type="bibr" rid="bib31">Kalucka et al., 2020</xref>; <xref ref-type="bibr" rid="bib48">Vanlandewijck et al., 2018</xref>), and it remains a future task to evaluate physiological and pathophysiological roles of RPTPγ in these individual blood vessel segments. Transcript levels for <italic>Ptprg</italic> appear particularly high in a smaller subset of endothelial cells (up to 20–40%, depending on the vascular bed; <xref ref-type="fig" rid="fig1">Figure 1C–E</xref>), which raises the intriguing possibility that a distinct population of endothelial cells act as the primary sensors of the metabolic environment.</p><p>Hyperventilation-induced cerebral vasoconstriction can cause syncope but is also a therapeutic tool for rapidly reducing cerebral blood flow, capillary filtration, and intracranial pressure. Hypocapnia during hyperventilation leads to decreased [HCO<sub>3</sub><sup>–</sup>] and alkalosis (<xref ref-type="table" rid="table1">Table 1</xref>); and the current study demonstrates that RPTPγ is necessary for approximately 30% of the associated decrease in cerebral perfusion (<xref ref-type="fig" rid="fig6">Figure 6F</xref>).</p><p>In conclusion, the single-pass transmembrane protein RPTPγ enhances endothelium-dependent vasorelaxation of resistance arteries—by amplifying endothelial intracellular Ca<sup>2+</sup> responses, NO synthesis, and EDH-type responses—and adjusts cerebral perfusion during increased neuronal activity and acid-base disturbances. Although RPTPγ shows no major impact on resting blood pressure, it contributes markedly to the blood pressure increase observed during hyperventilation. Supporting the translational value of our findings, predicted loss-of-function variants in <italic>PTPRG</italic> are associated with human ischemic vascular disease in the brain and heart. The influence of RPTPγ on vascular resistance specifically in tissues with disturbed acid-base composition makes RPTPγ a promising focus for targeted therapeutic intervention against ischemia.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>RPTPγ KO mice (MGI:3663183) from Dr. Joseph Schlessinger, Yale University, USA (<xref ref-type="bibr" rid="bib32">Lamprianou et al., 2006</xref>), were kindly provided by Dr. Walter F. Boron, Case Western Reserve University, USA (<xref ref-type="bibr" rid="bib55">Zhou et al., 2016</xref>). The transgenic mice were originally generated by inserting an internal ribosome entry site–β-galactosidase–neomycin–poly(A) cassette immediately 3’ of exon 1 (<xref ref-type="bibr" rid="bib32">Lamprianou et al., 2006</xref>). Homologous recombination in W4 129S6/SvEv mouse embryonic stem cells (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_Y634">CVCL_Y634</ext-link>) was achieved following electroporation, and correctly targeted embryonic stem cells were used for embryo aggregation to achieve germ line chimeras (<xref ref-type="bibr" rid="bib32">Lamprianou et al., 2006</xref>). At the time of experiments, the transgene-carrying mice had been backcrossed to the C57BL/6 line for at least eight generations. In total, we used 125 WT and 112 RPTPγ KO mice that were kept on a 12 hr light/12 hr dark cycle with ad libitum access to tap water and chow (Altromin 1324; Brogaarden, Danmark). We used Eco-Pure Aspen Chips 2 Premium cage bedding (Datesand, UK). Genomic DNA used for genotyping was isolated from tail biopsies collected at weening and again after sacrifice. All animal experimental procedures were approved by the Danish Animal Experiments Inspectorate (2016-15-0201-00982).</p><sec id="s4-1"><title>Small vessel myography</title><p>Male RPTPγ KO and matched WT mice (&gt;8 weeks old) deeply anesthetized by intraperitoneal injection of pentobarbital were sacrificed by exsanguination. Approximately 2 mm long segments of basilar, mesenteric, and coronary septal arteries were dissected under a stereomicroscope, mounted in four-channel wire myographs (610M; DMT, Denmark) for isometric investigation, heated to 37°C, and normalized to 90% of the internal diameter corresponding to a transmural pressure of 100 mmHg (<xref ref-type="bibr" rid="bib38">Mulvany and Halpern, 1977</xref>). The myograph chambers were aerated with 5% CO<sub>2</sub>/balance air (for CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing physiological saline solutions) or nominally CO<sub>2</sub>-free air (for CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free solutions). The CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solution consisted of (in mM): 119 NaCl, 22 NaHCO<sub>3</sub>, 10 HEPES, 1.2 MgSO<sub>4</sub>, 2.82 KCl, 5.5 glucose, 1.18 KH<sub>2</sub>PO<sub>4</sub>, 0.03 EDTA, 1.6 CaCl<sub>2</sub>. The CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free solution was produced by substituting NaHCO<sub>3</sub> with NaCl. HEPES is necessary for pH control in the CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free solution; and we included HEPES also in the CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solution in order to separate vascular effects of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> omission from potential effects of adding HEPES (<xref ref-type="bibr" rid="bib3">Altura et al., 1980</xref>). For the control experiments in <xref ref-type="fig" rid="fig2">Figures 2C</xref> and <xref ref-type="fig" rid="fig3">3C</xref>, we used a CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solution without HEPES, i.e., where the 10 mM HEPES was substituted with 5 mM NaCl. After all contents were added, the solutions were vigorously bobbled with the appropriate CO<sub>2</sub>-containing or nominally CO<sub>2</sub>-free gas mixture at 37°C before pH was adjusted to 7.40 while allowing ample time for buffer equilibration. Arterial force was acquired using a PowerLab 4/25 recorder and LabChart 7 Pro software (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001620">SCR_001620</ext-link>; ADInstruments, New Zealand). As standard warm-up protocol, arteries were exposed twice to 3 µM of the thromboxane A<sub>2</sub> analog U46619 for 2 min, and arteries that produced less than 1 mN force were excluded from further analysis. Vasorelaxation in response to acetylcholine, the PAR2 agonist SLIGRL-amide, and the NO-donors SNAP, and spermine NONOate was tested in U46619-contracted arteries that developed stable tension equivalent to ~70% of the maximal response during the standard warm-up procedure. Vasorelaxation, from the pre-contraction level, was quantified as the relative decrease in active tone during the last 30 s of each 2 min agonist application. We used two NO donors that differ, for instance, in their rate and location of NO release (<xref ref-type="bibr" rid="bib22">Bradley and Steinert, 2015</xref>). Because acetylcholine-induced vasorelaxation shows substantial tachyphylaxis in arteries from C57BL/6 mice, we tested single doses of acetylcholine applied on separate U46619 pre-contractions. In contrast, SLIGRL-amide does not show this degree of tachyphylaxis, and we therefore tested its vasorelaxant properties through cumulative additions.</p></sec><sec id="s4-2"><title>Endothelial Ca<sup>2+</sup> measurements</title><p>Ca<sup>2+</sup>-sensitive fluorophores were loaded preferentially into endothelial cells by slow (~1 mL/hr for 45 min) perfusion of physiological saline solution containing 2.5 µM Fluo-4 and 3.5 µM Fura Red (Invitrogen) through the lumen of basilar and mesenteric arteries mounted in a pressure myograph (120CP; DMT) (<xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>). The cell permeant acetoxymethyl ester (AM) forms of the fluorophores were first solubilized in a load mix containing dimethyl sulfoxide, Pluronic F127, and Cremophor EL. The loaded arteries were next mounted in a confocal wire myograph (360CW; DMT) and studied using a Zeiss Axiovert 200M confocal microscope equipped with an LSM Pascal exciter and a 40 × objective (LD C-Apochromat; N.A. 1.10; Zeiss, Germany). The arteries were excited at 488 nm and emission light collected at wavelengths in the range of 505–530 nm (<italic>F</italic><sub>505-530</sub>; representing Fluo-4 signals that increase at elevated [Ca<sup>2+</sup>]) and longer than 600 nm (<italic>F</italic><sub>&gt;600</sub>; representing Fura Red signals that decrease at elevated [Ca<sup>2+</sup>]). Arteries with no or only solitary loaded endothelial cells were excluded from analysis. The <italic>F</italic><sub>505-530</sub>/<italic>F</italic><sub>&gt;600</sub> ratio normalized to the baseline ratio (the first 2 min of the recording) was used to evaluate relative intracellular Ca<sup>2+</sup> dynamics.</p></sec><sec id="s4-3"><title>Endothelial intracellular pH measurements</title><p>Inverted basilar and mesenteric arteries were mounted on a 40 µm wire in a confocal wire myograph (360CW, DMT) and loaded with the pH-sensitive fluorophore 2',7'-bis-(2-carboxyethyl)−5-(and-6)-carboxyfluorescein (BCECF) in physiological saline solution (1 µM BCECF-AM in 0.05‰ DMSO) to preferentially load endothelial cells, essentially as previously described (<xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>; <xref ref-type="bibr" rid="bib18">Boedtkjer and Aalkjaer, 2009</xref>). The loaded arteries were studied using an Olympus IX83 microscope equipped with a 20 × objective (LUCPlanFLN; N.A. 0.45; Olympus, Japan) and an ORCA-Flash 4.0 camera (Hamamatsu, Japan). The arteries were alternatingly excited at 490 and 436 nm and emission light collected at 530 nm. The <italic>F</italic><sub>490</sub>/<italic>F</italic><sub>436</sub> fluorescence ratio was calibrated to intracellular pH using the high-[K<sup>+</sup>] nigericin method (<xref ref-type="bibr" rid="bib18">Boedtkjer and Aalkjaer, 2009</xref>; <xref ref-type="bibr" rid="bib1">Aalkjaer and Cragoe, 1988</xref>), which in arteries agrees well with the null-point technique (<xref ref-type="bibr" rid="bib28">Danielsen et al., 2013</xref>). Steady-state intracellular pH was recorded in the presence and absence of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>.</p></sec><sec id="s4-4"><title>Membrane potential recordings</title><p>Membrane potentials were measured in vascular smooth muscle cells of isolated basilar arteries using sharp electrodes as previously described (<xref ref-type="bibr" rid="bib13">Boedtkjer et al., 2013a</xref>). The arteries were mounted in a wire myograph (420A; DMT) and microelectrodes that had resistances of 40–120 MΩ when backfilled with 3 M KCl were inserted into the vascular wall from the adventitial side. Cell impalement was observed as a sudden drop in voltage followed by sharp return to baseline upon retraction. Measurements with more than 10 mV difference between the baseline recording before and after impalement were excluded from analysis.</p></sec><sec id="s4-5"><title><italic>LacZ</italic> reporter studies</title><p>The genetic insert that disrupts RPTPγ expression in the employed KO mice contains a promotorless <italic>LacZ</italic> sequence allowing for β-galactosidase expression under control of the <italic>Ptprg</italic> promotor (<xref ref-type="bibr" rid="bib32">Lamprianou et al., 2006</xref>). Four homozygous KO mice (<italic>Ptprg<sup>LacZ/LacZ</sup></italic>) and two WT mice were perfusion fixed with 4% (weight/volume) paraformaldehyde in phosphate-buffered saline (PBS, in mM: 137 NaCl, 2.5 KCl, 4.3 Na<sub>2</sub>HPO<sub>4</sub>, and 1 KH<sub>2</sub>PO<sub>4</sub>) and investigated for promoter activity essentially as previously described (<xref ref-type="bibr" rid="bib10">Boedtkjer et al., 2008</xref>). Segments of basilar, middle cerebral, gracilis, coronary, mesenteric, and pulmonary arteries as well as thoracic aorta were dissected free from surrounding tissue and washed in PBS overnight at 4°C. The arteries were then placed in staining solution (in mM: 5 K<sub>4</sub>Fe(CN)<sub>6</sub>, 5 K<sub>3</sub>Fe(CN)<sub>6</sub>, 2 MgCl<sub>2</sub>, 0.1% (weight/volume) sodium dodecyl sulfate (SDS), 0.1% (volume/volume) TWEEN−20, and 0.1% (weight/volume) 5-bromo-4-chloro-indolyl-13-D-galactoside (X-Gal)) for 24 hr at room temperature (~21°C). Finally, samples were transferred to PBS containing 1% (weight/volume) ethylenediaminetetraacetic acid (EDTA) and 4% paraformaldehyde in order to stop the staining reaction. Whole mount micrographs of the arteries were captured using a Leica M165 C stereomicroscope equipped with a Leica M170 HD camera (Germany). In addition, we paraffin-embedded and cut basilar and middle cerebral arteries—that showed the strongest staining—to 4-µm-thick histological sections that were visualized on an upright Leica DM light microscope equipped with a Leica DM300 digital camera in order to identify the cellular expression pattern.</p></sec><sec id="s4-6"><title>Reverse transcription and quantitative polymerase chain reaction</title><p>Arteries dissected free from surrounding tissue in cold physiological saline solution were stored in RNALater (Qiagen, Denmark) at 4°C. The isolated arteries were homogenized in RLT lysis buffer (Qiagen) using a TissueLyser II (Qiagen) at 30 Hz for 2 min. RNA was isolated using the RNeasy Micro Qiacube kit including carrier RNA (Qiagen). Samples were reverse transcribed using random decamer primers and Superscript III Reverse Transcriptase (Invitrogen, Fisher Scientific, Denmark). Reactions without reverse transcriptase were performed in order to test for genomic amplification. Quantitative PCR was performed on an MX3000P system (Agilent, USA) based on Maxima Hot Start Taq DNA polymerase (ThermoFisher, Denmark). <italic>Ptprg</italic> mRNA levels relative to the reference genes <italic>Rn18s</italic> (18S ribosomal subunit) and <italic>Actb</italic> (β-actin) were evaluated in the different vascular beds based on the 2<sup>–ΔΔC<sub>T</sub></sup> method (<xref ref-type="bibr" rid="bib34">Livak and Schmittgen, 2001</xref>). We used the following forward (F) and reverse (R) primers and probes (P) purchased from Eurofins Genomics (Germany): <italic>Ptprg</italic> (F: 5’ <named-content content-type="sequence">TGG TTA CAA CAA AGC GAA AGC CT</named-content> 3’, R: 5’ <named-content content-type="sequence">ATA CTG ATC ACA CTT TCT CCT TCC</named-content> 3’, P: 5’ <named-content content-type="sequence">ATC TGG GAA CAA AAC ACG GGA ATC ATC AT</named-content> 3’), <italic>Rn18s</italic> (F: 5’ <named-content content-type="sequence">AAT AGC CTT CGC CAT CAC TGC</named-content> 3', R: 5’ <named-content content-type="sequence">GTG AGG TCG ATG TCT GCT TTC C</named-content> 3’, P: 5’ <named-content content-type="sequence">TGG GGC GGA GAT ATG CTC ATG TGG TGT T</named-content> 3’), and <italic>Actb</italic> (F: 5’ <named-content content-type="sequence">TGA CGT TGA CAT CCG TAA AG</named-content> 3’, R: 5’ <named-content content-type="sequence">CTG GAA GGT GGA CAG TGA GG</named-content> 3’ and P: 5’ <named-content content-type="sequence">AGT GCT GTC TGG TGG TAC CAC CAT GTA CC</named-content> 3’). Probes were modified with 5’ 6-FAM and 3’ TAMRA. Each reaction consisted of 10 min at 95°C followed by 50 cycles of 30 s at 95°C, 60 s at 55°C, and 60 s at 72°C.</p></sec><sec id="s4-7"><title>Single-cell RNA sequencing data</title><p>We explored levels of <italic>Ptprg</italic> transcripts in individual endothelial cells based on the EC Atlas database from VIB-KU Leuven, which is accessible at <ext-link ext-link-type="uri" xlink:href="https://endotheliomics.shinyapps.io/ec_atlas/">https://endotheliomics.shinyapps.io/ec_atlas/</ext-link> (downloaded on 11 June 2020). This online database includes data from a recent single-cell RNA sequencing study on endothelial cells from healthy mice (<xref ref-type="bibr" rid="bib31">Kalucka et al., 2020</xref>).</p></sec><sec id="s4-8"><title>Immunoblotting</title><p>We determined protein expression levels of eNOS in basilar and mesenteric arteries by immunoblotting using previously described antibodies (<xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>; <xref ref-type="bibr" rid="bib49">Voss et al., 2019</xref>). Arteries were snap frozen in liquid nitrogen and then homogenized using pellet pestles (Sigma-Aldrich, Denmark) in a lysis buffer at pH 7.5 containing (in mM) 20 Tris-HCl, 150 NaCl, 5 ethylene glycol tetraacetic acid (EGTA), 10 NaF, 20 β-glycerophosphate sodium salt, and HALT protease and phosphatase inhibitor cocktail (Thermo Scientific, Denmark). Samples were sonicated for 45 s and centrifuged at ~16,000 g for 10 min. Total protein concentrations in the supernatants were measured using a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific); and 10 µg total protein diluted in Laemmlie sample buffer (Biorad, Denmark) was loaded in each lane of an SDS polyacrylamide gel (Biorad). Membranes were first probed with anti-eNOS (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_304967">AB_304967</ext-link>; 0.2 µg/mL ab5589; Abcam, UK) or anti-pan-actin (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2313904">AB_2313904</ext-link>; 40 ng/mL #4968; Cell Signaling Technology, USA) primary antibody and then with secondary goat anti-rabbit antibody (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2099233">AB_2099233</ext-link>; 30 ng/mL #7074; Cell Signaling Technology) conjugated to horseradish peroxidase. Bound antibody was detected by enhanced chemiluminescence (ECL Plus; GE Healthcare, Denmark) using an ImageQuant LAS 4000 luminescent image analyzer (GE Healthcare). Densitometric analyses were performed using ImageJ software (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link>; Rasband; NIH, USA). Band densities of eNOS relative to pan-actin were reported after normalization to the average WT level.</p></sec><sec id="s4-9"><title>Blood pressure measurements</title><p>Mice were anesthetized by subcutaneous injection of ketamine and xylazine (80 mg/kg Ketaminol vet and 8 mg/kg Narcoxyl vet; Intervet International, The Netherlands) and placed on a thermostatically controlled heating platform.</p><p>For telemetry-based measurements of resting blood pressure and effects of L-NAME ingestion, the catheter of a telemetry transmitter (HD-X11; Data Sciences International, USA) was inserted in the common carotid artery through a midline incision in the neck, and the transmitter body placed in a subcutaneous pocket during stereomicroscopy. Pain relief was achieved through subcutaneous injection of buprenorphine (0.2 mL/kg, Temgesic, Schering-Plough, Europe). Telemetry measurements started one week after the operation. One 48 hr long registration at baseline was followed by two 72 hr long registrations during which first 0.5 mg/mL and then 3 mg/mL L-NAME was added to the drinking water. Telemetry signals were recorded for 10 s every minute using Dataquest A.R.T. 4.3 and analyzed with Ponemah 5.0 software (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_017107">SCR_017107</ext-link>; Data Sciences International). We evaluated daytime and nighttime blood pressure from 11 AM to 1 PM and 11 PM to 1 AM, respectively.</p><p>For measurements of acute blood pressure responses to hyperventilation, a catheter was inserted in the common carotid artery through a midline incision and connected to a pressure transducer (MLT0699, ADInstruments). The mice were intubated and ventilated on a Minivent type 845 ventilator (Harvard Apparatus, USA) at a frequency of 125 min<sup>−1</sup> and with tidal volume adjusted until capnography readings (Capnograph Type 240, Hugo-Sachs Electronics, Germany) showed an F<sub>ET</sub>CO<sub>2</sub> of 3.5%. During experiments, hypocapnia was induced by elevating the ventilation until F<sub>ET</sub>CO<sub>2</sub> decreased to 2%. Mean arterial blood pressure was derived from the pressure traces using the blood pressure add-on for LabChart 8 Pro (ADInstruments). A few mice with an initial systolic blood pressure below 70 mmHg were excluded from the analysis.</p></sec><sec id="s4-10"><title>Laser speckle imaging</title><p>Mice were initially anesthetized by subcutaneous injection of ketamine (80 mg/kg) and xylazine (8 mg/kg) followed by injection with 1/4 the initial dose every 45 min. After endotracheal intubation, mice were ventilated under capnography control as described above. The head of the anesthetized mouse was fixed in an adaptor for a stereotaxic frame (World Precision Instruments, UK) while the rest of the body was kept warm on a heating pad (Fine Science Tools Inc, Canada). The skin covering the top of the skull was removed, the surface of the bone cleaned, and a coverslip mounted in agarose in order to minimize optical reflections. Whiskers were fixed to a metal pole mounted on a cylindrical solenoid controlled by an Arduino circuit (Funduino Kit, Germany). The whiskers on one side of the head were first stimulated by moving whiskers vertically with an amplitude of 8 mm and frequency of 4 Hz. Then, the stimulation protocol was repeated on the opposite side of the head, and the two responses were averaged for each mouse. Whisker stimulation was performed under control conditions (F<sub>ET</sub>CO<sub>2</sub> = 3.5%) and after F<sub>ET</sub>CO<sub>2</sub> was reduced to 2% by mechanical hyperventilation.</p><p>Speckle images of 1088 × 1088 pixels were captured with a Basler acA2000-165uc camera mounted on a VZM 200i Zoom Imaging Lens (Edmund Optics, USA) during transcranial illumination with near-infrared laser light (CLD 1011LP, Thorlabs Inc, USA). Speckle data were analyzed with MATLAB software (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001622">SCR_001622</ext-link>; MathWorks, USA). In each experiment, values were calculated for a region of interest (100 × 100 pixels) in the second posterior bifurcation of the middle cerebral artery corresponding to the somatosensory barrel cortex contralateral to the whisker stimulation (<xref ref-type="bibr" rid="bib4">Aronoff and Petersen, 2008</xref>).</p></sec><sec id="s4-11"><title>Arterial blood gas measurements</title><p>Arterial blood samples were collected through a catheter implanted in the common carotid artery of anesthetized, intubated mice ventilated to normocapnia (F<sub>ET</sub>CO<sub>2</sub> = 3.5%) or experimental hypocapnia (F<sub>ET</sub>CO<sub>2</sub> = 2%) on a Minivent type 845 ventilator (Harvard Apparatus). The blood was immediately analyzed using an ABL80 Flex blood gas analyzer (Radiometer, Denmark).</p></sec><sec id="s4-12"><title>Statistics of mouse experiments</title><p>Data are expressed as mean ± SEM and n equals number of mice (i.e. biological replicates). Probability (p) values less than 0.05 were considered statistically significant. Sample sizes were selected based on previous experience (<xref ref-type="bibr" rid="bib9">Boedtkjer et al., 2006</xref>; <xref ref-type="bibr" rid="bib16">Boedtkjer et al., 2016c</xref>; <xref ref-type="bibr" rid="bib11">Boedtkjer et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Thomsen et al., 2014</xref>) to allow detection of biologically relevant differences. If distributions were approximately Gaussian and variances equal between groups, we compared (a) one variable between two groups using unpaired two-tailed Student’s <italic>t</italic>-test, (b) one variable between three or more groups using one-way ANOVA followed by Dunnett’s post-tests, and (c) effects of two variables on a third variable using two-way ANOVA followed by Sidak’s post-tests. If the distributions showed unequal variance (i.e. p&lt;0.05 by <italic>F</italic> test or by Brown-Forsythe and Bartlett’s tests) or significant difference from normality (i.e. p&lt;0.05 by D'Agostino and Pearson or Shapiro-Wilk normality tests) due to right-skewness, we performed square root- or log-transformation. If variances were still unequal, we compared one variable between two groups based on unpaired two-tailed <italic>t</italic>-tests with Welch’s correction. If data distributions still did not pass normality tests, we used the non-parametric Mann-Whitney test to compare one variable between two groups. Concentration-response relationships were fitted to sigmoidal functions using least-square regression analyses, and the derived log(EC<sub>50</sub>), Hill Slope, and bottom values were compared using extra sum-of-squares <italic>F</italic>-tests. Investigators were not blinded for genotype during experiments. Data processing and statistical analyses were performed using Microsoft Office Excel 2016 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016137">SCR_016137</ext-link>) and GraphPad Prism 7.05 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link>) software.</p></sec><sec id="s4-13"><title>Burden analysis of loss-of-function variants</title><p>We studied association between rare variation in <italic>PTPRG</italic> and human ischemic vascular disease based on exome sequencing data covering ~50,000 participants from the UK Biobank (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_012815">SCR_012815</ext-link>), which is a cohort with deep genetic and phenotypic data collected from the United Kingdom (<xref ref-type="bibr" rid="bib24">Bycroft et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Van Hout et al., 2019</xref>).</p><p>Population-level variants (UK Biobank data field 23170) generated with the Functionally Equivalent pipeline (<xref ref-type="bibr" rid="bib40">Regier et al., 2018</xref>) were used after ensuring that the genomic region containing <italic>PTPRG</italic> was unaffected by the current known error in the exome analysis protocol (UK Biobank Resource 3802). We predicted the consequences of alternative alleles within the full-length transcript for <italic>PTPRG</italic> (ENST00000474889.6) using the Ensembl Variant Effect Predictor (VEP) (<xref ref-type="bibr" rid="bib36">McLaren et al., 2016</xref>); and included in our analyses, the 334 missense variants localized outside exon-intron boundary regions and 75 variants with predicted loss-of-function. Carriers of the identified variants were extracted using the R-package qgg (<xref ref-type="bibr" rid="bib41">Rohde et al., 2020</xref>). The identified loss-of-function variants included 36 with low (intronic splice region variants, synonymous splice region variants), 17 with moderate (in-frame insertions, in-frame deletions, missense splice region variants), and 22 with high (splice acceptor variants, splice donor variants, stop-gain variants, frameshift variants) predicted impact. In total, we identified 29,975 individuals who carried at least one missense variant and 195 individuals, who carried a variant with predicted loss-of-function. Of the 195 loss-of-function carriers, 123, 32, and 40 individuals carried variants with low, moderate, and high predicted impact, respectively.</p><p>Known disease diagnoses for UK Biobank participants (data field 41270) were extracted from hospital inpatient records coded according to the International Classification of Disease, version 10 (ICD-10; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_010349">SCR_010349</ext-link>). Amongst the 49,953 participants with exome data, 2529 individuals were diagnosed with angina pectoris (I20), 972 with acute myocardial infarction (I21), 392 with cerebral ischemia (I63), and 153 with vascular intestinal disorders (K55.0). Self-reported health status was extracted for angina (data field 1074; reported by 1621 individuals), heart attack (data field 1075; reported by 1158 individuals), and stroke (data field 1081; reported by 686 individuals). We further extracted MRI-based values for 12,851 exome-sequenced individuals for whom left ventricular ejection fraction (data field 22420) was available from a fully automated analysis approach that has shown good correlation with manual analysis results performed by trained readers (<xref ref-type="bibr" rid="bib45">Suinesiaputra et al., 2018</xref>). The cardiac MRI data set included 6482 carriers of missense <italic>PTPRG</italic> variants, 32 carriers of low impact loss-of function variants, 13 carriers of moderate impact loss-of-function variants, and 13 carriers of high impact loss-of-function variants.</p><p>We performed logistic regression analyses to calculate odds ratios (± SEM) for carrying missense or predicted loss-of-function <italic>PTPRG</italic> variants when diagnosed with ischemic vascular disease. We fist evaluated acute ischemic vascular disease as a whole for the brain, heart, and intestine (aggregate of ICD-10 diagnosis codes I20, I21, I63, and K55.0). For the group of individuals carrying a predicted loss-of-function variant of moderate or high impact, we then calculated separate odds ratios for I20, I21, and I63. The number of exome-sequenced participants in the UK Biobank diagnosed with K55.0 was too low for a meaningful separate statistical analysis. We next evaluated association of the <italic>PTPRG</italic> loss-of-function variants with self-reported angina, heart attack, and stroke. Finally, we evaluated the relation between carrier status for <italic>PTPRG</italic> variants and left ventricular ejection fraction by multiple linear regression analysis. The logistic as well as multiple linear regression analyses were corrected for sex (data field 31), age (data field 21022), body mass index (data field 21001), the first four genetic principal components (data field 22009), smoking status (data field 20116), dyslipidemia (ICD-10 diagnosis code E78.5), diabetes mellitus (ICD-10 diagnosis code E11), and hypertension (ICD-10 diagnosis code I10).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors wish to thank Drs. Joseph Schlessinger (Yale University) and Walter F Boron (Case Western Reserve University) for generously providing the RPTPγ KO mice. We are grateful to Dr. Joanna Kalucka (Aarhus University) for assistance with the single-cell RNA sequencing analyses. We thank Viola Larsen, Liisa Jacobsen, Jørgen Andresen, and Jane Rønn (Aarhus University) for expert technical assistance. Access to the UK Biobank resource was approved under application number 60032.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Human subjects: The research based on the UK Biobank resource was conducted under Application Number 60032.</p></fn><fn fn-type="other" id="fn2"><p>Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Protocols were approved by the Danish Animal Experiments Inspectorate (2016-15-0201-00982). All surgery was performed under general anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-57553-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are presented in the manuscript.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aalkjaer</surname> <given-names>C</given-names></name><name><surname>Cragoe</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Intracellular pH regulation in resting and contracting segments of rat mesenteric resistance vessels</article-title><source>The Journal of Physiology</source><volume>402</volume><fpage>391</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1988.sp017211</pub-id><pub-id pub-id-type="pmid">2976824</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aalkjaer</surname> <given-names>C</given-names></name><name><surname>Hughes</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Chloride and bicarbonate transport in rat resistance arteries</article-title><source>The Journal of Physiology</source><volume>436</volume><fpage>57</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1991.sp018539</pub-id><pub-id pub-id-type="pmid">2061847</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altura</surname> <given-names>BM</given-names></name><name><surname>Altura</surname> <given-names>BT</given-names></name><name><surname>Carella</surname> <given-names>A</given-names></name><name><surname>Turlapaty</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Adverse effects of artificial buffers on contractile responses of arterial and venous smooth muscle</article-title><source>British Journal of Pharmacology</source><volume>69</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.1980.tb07892.x</pub-id><pub-id pub-id-type="pmid">6254589</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronoff</surname> <given-names>R</given-names></name><name><surname>Petersen</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Layer, column and cell-type specific genetic manipulation in mouse barrel cortex</article-title><source>Frontiers in Neuroscience</source><volume>2</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.3389/neuro.01.001.2008</pub-id><pub-id pub-id-type="pmid">18982108</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baretella</surname> <given-names>O</given-names></name><name><surname>Xu</surname> <given-names>A</given-names></name><name><surname>Vanhoutte</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Acidosis prevents and alkalosis augments endothelium-dependent contractions in mouse arteries</article-title><source>Pflügers Archiv - European Journal of Physiology</source><volume>466</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1007/s00424-013-1323-z</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnea</surname> <given-names>G</given-names></name><name><surname>Silvennoinen</surname> <given-names>O</given-names></name><name><surname>Shaanan</surname> <given-names>B</given-names></name><name><surname>Honegger</surname> <given-names>AM</given-names></name><name><surname>Canoll</surname> <given-names>PD</given-names></name><name><surname>D'Eustachio</surname> <given-names>P</given-names></name><name><surname>Morse</surname> <given-names>B</given-names></name><name><surname>Levy</surname> <given-names>JB</given-names></name><name><surname>Laforgia</surname> <given-names>S</given-names></name><name><surname>Huebner</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Identification of a carbonic anhydrase-like domain in the extracellular region of RPTPγ defines a new subfamily of receptor tyrosine phosphatases</article-title><source>Molecular and Cellular Biology</source><volume>13</volume><fpage>1497</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1128/MCB.13.3.1497</pub-id><pub-id pub-id-type="pmid">8382771</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname> <given-names>AJ</given-names></name><name><surname>Ugochukwu</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>WH</given-names></name><name><surname>King</surname> <given-names>ON</given-names></name><name><surname>Filippakopoulos</surname> <given-names>P</given-names></name><name><surname>Alfano</surname> <given-names>I</given-names></name><name><surname>Savitsky</surname> <given-names>P</given-names></name><name><surname>Burgess-Brown</surname> <given-names>NA</given-names></name><name><surname>Müller</surname> <given-names>S</given-names></name><name><surname>Knapp</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Large-scale structural analysis of the classical human protein tyrosine phosphatome</article-title><source>Cell</source><volume>136</volume><fpage>352</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.11.038</pub-id><pub-id pub-id-type="pmid">19167335</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batlle</surname> <given-names>DC</given-names></name><name><surname>Peces</surname> <given-names>R</given-names></name><name><surname>LaPointe</surname> <given-names>MS</given-names></name><name><surname>Ye</surname> <given-names>M</given-names></name><name><surname>Daugirdas</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Cytosolic free calcium regulation in response to acute changes in intracellular pH in vascular smooth muscle</article-title><source>American Journal of Physiology-Cell Physiology</source><volume>264</volume><fpage>C932</fpage><lpage>C943</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1993.264.4.C932</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Praetorius</surname> <given-names>J</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>NBCn1 (slc4a7) mediates the Na<sup>+</sup>-dependent bicarbonate transport important for regulation of intracellular pH in mouse vascular smooth muscle cells</article-title><source>Circulation Research</source><volume>98</volume><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000204750.04971.76</pub-id><pub-id pub-id-type="pmid">16439691</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Praetorius</surname> <given-names>J</given-names></name><name><surname>Füchtbauer</surname> <given-names>EM</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Antibody-independent localization of the electroneutral Na<sup>+</sup>-HCO<sub>3</sub><sup>–</sup> cotransporter NBCn1 (slc4a7) in mice</article-title><source>American Journal of Physiology-Cell Physiology</source><volume>294</volume><fpage>C591</fpage><lpage>C603</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00281.2007</pub-id><pub-id pub-id-type="pmid">18077606</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Praetorius</surname> <given-names>J</given-names></name><name><surname>Matchkov</surname> <given-names>VV</given-names></name><name><surname>Stankevicius</surname> <given-names>E</given-names></name><name><surname>Mogensen</surname> <given-names>S</given-names></name><name><surname>Füchtbauer</surname> <given-names>AC</given-names></name><name><surname>Simonsen</surname> <given-names>U</given-names></name><name><surname>Füchtbauer</surname> <given-names>EM</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Disruption of Na<sup>+</sup>,HCO<sub>3</sub>⁻ cotransporter NBCn1 (slc4a7) inhibits NO-mediated vasorelaxation, smooth muscle Ca<sup>2+</sup> sensitivity, and hypertension development in mice</article-title><source>Circulation</source><volume>124</volume><fpage>1819</fpage><lpage>1829</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.015974</pub-id><pub-id pub-id-type="pmid">21947296</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Damkier</surname> <given-names>HH</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NHE1 knockout reduces blood pressure and arterial media/lumen ratio with no effect on resting pH<sub>i</sub> in the vascular wall</article-title><source>The Journal of Physiology</source><volume>590</volume><fpage>1895</fpage><lpage>1906</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2011.227132</pub-id><pub-id pub-id-type="pmid">22351634</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Endothelial alkalinisation inhibits gap junction communication and endothelium-derived hyperpolarisations in mouse mesenteric arteries</article-title><source>The Journal of Physiology</source><volume>591</volume><fpage>1447</fpage><lpage>1461</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2012.247478</pub-id><pub-id pub-id-type="pmid">23297309</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Matchkov</surname> <given-names>VV</given-names></name><name><surname>Boedtkjer</surname> <given-names>DM</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Negative news: Cl<sup>–</sup> and HCO<sub>3</sub><sup>–</sup> in the vascular wall</article-title><source>Physiology</source><volume>31</volume><fpage>370</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1152/physiol.00001.2016</pub-id><pub-id pub-id-type="pmid">27511463</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Bentzon</surname> <given-names>JF</given-names></name><name><surname>Dam</surname> <given-names>VS</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Na<sup>+</sup>, HCO<sub>3</sub><sup>–</sup>-cotransporter NBCn1 increases pH<sub>i</sub> gradients, Filopodia, and migration of smooth muscle cells and promotes arterial remodelling</article-title><source>Cardiovascular Research</source><volume>111</volume><fpage>227</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvw079</pub-id><pub-id pub-id-type="pmid">27076468</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Hansen</surname> <given-names>KB</given-names></name><name><surname>Boedtkjer</surname> <given-names>DMB</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name><name><surname>Boron</surname> <given-names>WF</given-names></name></person-group><year iso-8601-date="2016">2016c</year><article-title>Extracellular HCO<sub>3</sub><sup>–</sup> is sensed by mouse cerebral arteries: regulation of tone by receptor protein tyrosine phosphatase γ</article-title><source>Journal of Cerebral Blood Flow &amp; Metabolism</source><volume>36</volume><fpage>965</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1177/0271678X15610787</pub-id><pub-id pub-id-type="pmid">26661205</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Acid-base regulation and sensing: accelerators and brakes in metabolic regulation of cerebrovascular tone</article-title><source>Journal of Cerebral Blood Flow &amp; Metabolism</source><volume>38</volume><fpage>588</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1177/0271678X17733868</pub-id><pub-id pub-id-type="pmid">28984162</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Insulin inhibits Na<sup>+</sup>/H<sup>+</sup> exchange in vascular smooth muscle and endothelial cells in situ: involvement of H<sub>2</sub>O<sub>2</sub> and tyrosine phosphatase SHP-2</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>296</volume><fpage>H247</fpage><lpage>H255</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00725.2008</pub-id><pub-id pub-id-type="pmid">19036852</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Intracellular pH in the resistance vasculature: regulation and functional implications</article-title><source>Journal of Vascular Research</source><volume>49</volume><fpage>479</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1159/000341235</pub-id><pub-id pub-id-type="pmid">22907294</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Acid–base transporters modulate cell migration, growth and proliferation: Implications for structure development and remodeling of resistance arteries?</article-title><source>Trends in Cardiovascular Medicine</source><volume>23</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.tcm.2012.09.001</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boedtkjer</surname> <given-names>E</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Disturbed acid-base transport: an emerging cause of hypertension</article-title><source>Frontiers in Physiology</source><volume>4</volume><elocation-id>388</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2013.00388</pub-id><pub-id pub-id-type="pmid">24399970</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname> <given-names>SA</given-names></name><name><surname>Steinert</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Characterisation and comparison of temporal release profiles of nitric oxide generating donors</article-title><source>Journal of Neuroscience Methods</source><volume>245</volume><fpage>116</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2015.02.024</pub-id><pub-id pub-id-type="pmid">25749567</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucci</surname> <given-names>M</given-names></name><name><surname>Roviezzo</surname> <given-names>F</given-names></name><name><surname>Cirino</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Protease-activated receptor-2 (PAR2) in cardiovascular system</article-title><source>Vascular Pharmacology</source><volume>43</volume><fpage>247</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2005.07.009</pub-id><pub-id pub-id-type="pmid">16183333</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bycroft</surname> <given-names>C</given-names></name><name><surname>Freeman</surname> <given-names>C</given-names></name><name><surname>Petkova</surname> <given-names>D</given-names></name><name><surname>Band</surname> <given-names>G</given-names></name><name><surname>Elliott</surname> <given-names>LT</given-names></name><name><surname>Sharp</surname> <given-names>K</given-names></name><name><surname>Motyer</surname> <given-names>A</given-names></name><name><surname>Vukcevic</surname> <given-names>D</given-names></name><name><surname>Delaneau</surname> <given-names>O</given-names></name><name><surname>O'Connell</surname> <given-names>J</given-names></name><name><surname>Cortes</surname> <given-names>A</given-names></name><name><surname>Welsh</surname> <given-names>S</given-names></name><name><surname>Young</surname> <given-names>A</given-names></name><name><surname>Effingham</surname> <given-names>M</given-names></name><name><surname>McVean</surname> <given-names>G</given-names></name><name><surname>Leslie</surname> <given-names>S</given-names></name><name><surname>Allen</surname> <given-names>N</given-names></name><name><surname>Donnelly</surname> <given-names>P</given-names></name><name><surname>Marchini</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The UK biobank resource with deep phenotyping and genomic data</article-title><source>Nature</source><volume>562</volume><fpage>203</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0579-z</pub-id><pub-id pub-id-type="pmid">30305743</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carty</surname> <given-names>CL</given-names></name><name><surname>Keene</surname> <given-names>KL</given-names></name><name><surname>Cheng</surname> <given-names>YC</given-names></name><name><surname>Meschia</surname> <given-names>JF</given-names></name><name><surname>Chen</surname> <given-names>WM</given-names></name><name><surname>Nalls</surname> <given-names>M</given-names></name><name><surname>Bis</surname> <given-names>JC</given-names></name><name><surname>Kittner</surname> <given-names>SJ</given-names></name><name><surname>Rich</surname> <given-names>SS</given-names></name><name><surname>Tajuddin</surname> <given-names>S</given-names></name><name><surname>Zonderman</surname> <given-names>AB</given-names></name><name><surname>Evans</surname> <given-names>MK</given-names></name><name><surname>Langefeld</surname> <given-names>CD</given-names></name><name><surname>Gottesman</surname> <given-names>R</given-names></name><name><surname>Mosley</surname> <given-names>TH</given-names></name><name><surname>Shahar</surname> <given-names>E</given-names></name><name><surname>Woo</surname> <given-names>D</given-names></name><name><surname>Yaffe</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Sale</surname> <given-names>MM</given-names></name><name><surname>Dichgans</surname> <given-names>M</given-names></name><name><surname>Malik</surname> <given-names>R</given-names></name><name><surname>Longstreth</surname> <given-names>WT</given-names></name><name><surname>Mitchell</surname> <given-names>BD</given-names></name><name><surname>Psaty</surname> <given-names>BM</given-names></name><name><surname>Kooperberg</surname> <given-names>C</given-names></name><name><surname>Reiner</surname> <given-names>A</given-names></name><name><surname>Worrall</surname> <given-names>BB</given-names></name><name><surname>Fornage</surname> <given-names>M</given-names></name><collab>COMPASS and METASTROKE Consortia</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Meta-Analysis of Genome-Wide association studies identifies genetic risk factors for stroke in african americans</article-title><source>Stroke</source><volume>46</volume><fpage>2063</fpage><lpage>2068</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.115.009044</pub-id><pub-id pub-id-type="pmid">26089329</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Cann</surname> <given-names>MJ</given-names></name><name><surname>Litvin</surname> <given-names>TN</given-names></name><name><surname>Iourgenko</surname> <given-names>V</given-names></name><name><surname>Sinclair</surname> <given-names>ML</given-names></name><name><surname>Levin</surname> <given-names>LR</given-names></name><name><surname>Buck</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor</article-title><source>Science</source><volume>289</volume><fpage>625</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1126/science.289.5479.625</pub-id><pub-id pub-id-type="pmid">10915626</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname> <given-names>MR</given-names></name><name><surname>Derian</surname> <given-names>CK</given-names></name><name><surname>Leturcq</surname> <given-names>D</given-names></name><name><surname>Baker</surname> <given-names>SM</given-names></name><name><surname>Brunmark</surname> <given-names>A</given-names></name><name><surname>Ling</surname> <given-names>P</given-names></name><name><surname>Darrow</surname> <given-names>AL</given-names></name><name><surname>Santulli</surname> <given-names>RJ</given-names></name><name><surname>Brass</surname> <given-names>LF</given-names></name><name><surname>Andrade-Gordon</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues</article-title><source>Journal of Histochemistry &amp; Cytochemistry</source><volume>46</volume><fpage>157</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1177/002215549804600204</pub-id><pub-id pub-id-type="pmid">9446822</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielsen</surname> <given-names>AA</given-names></name><name><surname>Parker</surname> <given-names>MD</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Boron</surname> <given-names>WF</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name><name><surname>Boedtkjer</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Splice cassette II of Na<sup>+</sup>,HCO<sub>3</sub><sup>-</sup> cotransporter NBCn1 (slc4a7) interacts with calcineurin A: implications for transporter activity and intracellular pH control during rat artery contractions</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>8146</fpage><lpage>8155</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.455386</pub-id><pub-id pub-id-type="pmid">23382378</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname> <given-names>I</given-names></name><name><surname>Hecker</surname> <given-names>M</given-names></name><name><surname>Busse</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells</article-title><source>Circulation Research</source><volume>74</volume><fpage>1220</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1161/01.RES.74.6.1220</pub-id><pub-id pub-id-type="pmid">7514511</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaskell</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="1880">1880</year><article-title>On the tonicity of the heart and blood vessels</article-title><source>The Journal of Physiology</source><volume>3</volume><fpage>48</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1880.sp000083</pub-id><pub-id pub-id-type="pmid">16991305</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalucka</surname> <given-names>J</given-names></name><name><surname>de Rooij</surname> <given-names>L</given-names></name><name><surname>Goveia</surname> <given-names>J</given-names></name><name><surname>Rohlenova</surname> <given-names>K</given-names></name><name><surname>Dumas</surname> <given-names>SJ</given-names></name><name><surname>Meta</surname> <given-names>E</given-names></name><name><surname>Conchinha</surname> <given-names>NV</given-names></name><name><surname>Taverna</surname> <given-names>F</given-names></name><name><surname>Teuwen</surname> <given-names>LA</given-names></name><name><surname>Veys</surname> <given-names>K</given-names></name><name><surname>García-Caballero</surname> <given-names>M</given-names></name><name><surname>Khan</surname> <given-names>S</given-names></name><name><surname>Geldhof</surname> <given-names>V</given-names></name><name><surname>Sokol</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>R</given-names></name><name><surname>Treps</surname> <given-names>L</given-names></name><name><surname>Borri</surname> <given-names>M</given-names></name><name><surname>de Zeeuw</surname> <given-names>P</given-names></name><name><surname>Dubois</surname> <given-names>C</given-names></name><name><surname>Karakach</surname> <given-names>TK</given-names></name><name><surname>Falkenberg</surname> <given-names>KD</given-names></name><name><surname>Parys</surname> <given-names>M</given-names></name><name><surname>Yin</surname> <given-names>X</given-names></name><name><surname>Vinckier</surname> <given-names>S</given-names></name><name><surname>Du</surname> <given-names>Y</given-names></name><name><surname>Fenton</surname> <given-names>RA</given-names></name><name><surname>Schoonjans</surname> <given-names>L</given-names></name><name><surname>Dewerchin</surname> <given-names>M</given-names></name><name><surname>Eelen</surname> <given-names>G</given-names></name><name><surname>Thienpont</surname> <given-names>B</given-names></name><name><surname>Lin</surname> <given-names>L</given-names></name><name><surname>Bolund</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-Cell transcriptome atlas of murine endothelial cells</article-title><source>Cell</source><volume>180</volume><fpage>764</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.01.015</pub-id><pub-id pub-id-type="pmid">32059779</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamprianou</surname> <given-names>S</given-names></name><name><surname>Vacaresse</surname> <given-names>N</given-names></name><name><surname>Suzuki</surname> <given-names>Y</given-names></name><name><surname>Meziane</surname> <given-names>H</given-names></name><name><surname>Buxbaum</surname> <given-names>JD</given-names></name><name><surname>Schlessinger</surname> <given-names>J</given-names></name><name><surname>Harroch</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Receptor protein tyrosine phosphatase γ is a marker for pyramidal cells and sensory neurons in the nervous system and is not necessary for normal development</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>5106</fpage><lpage>5119</lpage><pub-id pub-id-type="doi">10.1128/MCB.00101-06</pub-id><pub-id pub-id-type="pmid">16782895</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassen</surname> <given-names>NA</given-names></name></person-group><year iso-8601-date="1968">1968</year><article-title>Brain extracellular pH: the main factor controlling cerebral blood flow</article-title><source>Scandinavian Journal of Clinical and Laboratory Investigation</source><volume>22</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.3109/00365516809167060</pub-id><pub-id pub-id-type="pmid">5741789</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>KJ</given-names></name><name><surname>Schmittgen</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>–ΔΔC<sub>T</sub></sup> method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname> <given-names>M-G</given-names></name><name><surname>Vanek</surname> <given-names>M</given-names></name><name><surname>Guerini</surname> <given-names>D</given-names></name><name><surname>Gasser</surname> <given-names>JA</given-names></name><name><surname>Jones</surname> <given-names>CE</given-names></name><name><surname>Junker</surname> <given-names>U</given-names></name><name><surname>Hofstetter</surname> <given-names>H</given-names></name><name><surname>Wolf</surname> <given-names>RM</given-names></name><name><surname>Seuwen</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Proton-sensing G-protein-coupled receptors</article-title><source>Nature</source><volume>425</volume><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/nature01905</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaren</surname> <given-names>W</given-names></name><name><surname>Gil</surname> <given-names>L</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Riat</surname> <given-names>HS</given-names></name><name><surname>Ritchie</surname> <given-names>GR</given-names></name><name><surname>Thormann</surname> <given-names>A</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Cunningham</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The ensembl variant effect predictor</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>122</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id><pub-id pub-id-type="pmid">27268795</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeish</surname> <given-names>AJ</given-names></name><name><surname>Dora</surname> <given-names>KA</given-names></name><name><surname>Garland</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Possible role for K<sup>+</sup> in endothelium-derived hyperpolarizing factor-linked dilatation in rat middle cerebral artery</article-title><source>Stroke</source><volume>36</volume><fpage>1526</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000169929.66497.73</pub-id><pub-id pub-id-type="pmid">15933259</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulvany</surname> <given-names>MJ</given-names></name><name><surname>Halpern</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats</article-title><source>Circulation Research</source><volume>41</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1161/01.RES.41.1.19</pub-id><pub-id pub-id-type="pmid">862138</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname> <given-names>JK</given-names></name><name><surname>Boedtkjer</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Carbonic anhydrase inhibitors modify intracellular pH transients and contractions of rat middle cerebral arteries during CO<sub>2</sub>/HCO<sub>3-</sub><sup>–</sup> fluctuations</article-title><source>Journal of Cerebral Blood Flow &amp; Metabolism</source><volume>38</volume><fpage>492</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1177/0271678X17699224</pub-id><pub-id pub-id-type="pmid">28318362</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regier</surname> <given-names>AA</given-names></name><name><surname>Farjoun</surname> <given-names>Y</given-names></name><name><surname>Larson</surname> <given-names>DE</given-names></name><name><surname>Krasheninina</surname> <given-names>O</given-names></name><name><surname>Kang</surname> <given-names>HM</given-names></name><name><surname>Howrigan</surname> <given-names>DP</given-names></name><name><surname>Chen</surname> <given-names>BJ</given-names></name><name><surname>Kher</surname> <given-names>M</given-names></name><name><surname>Banks</surname> <given-names>E</given-names></name><name><surname>Ames</surname> <given-names>DC</given-names></name><name><surname>English</surname> <given-names>AC</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Xing</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Matise</surname> <given-names>T</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Salerno</surname> <given-names>W</given-names></name><name><surname>Zody</surname> <given-names>MC</given-names></name><name><surname>Neale</surname> <given-names>BM</given-names></name><name><surname>Hall</surname> <given-names>IM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4038</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06159-4</pub-id><pub-id pub-id-type="pmid">30279509</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohde</surname> <given-names>PD</given-names></name><name><surname>Fourie Sørensen</surname> <given-names>I</given-names></name><name><surname>Sørensen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Qgg: an R package for large-scale quantitative genetic analyses</article-title><source>Bioinformatics</source><volume>36</volume><fpage>2614</fpage><lpage>2615</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz955</pub-id><pub-id pub-id-type="pmid">31883004</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname> <given-names>A</given-names></name><name><surname>Boron</surname> <given-names>WF</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Intracellular pH</article-title><source>Physiological Reviews</source><volume>61</volume><fpage>296</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1152/physrev.1981.61.2.296</pub-id><pub-id pub-id-type="pmid">7012859</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname> <given-names>R</given-names></name><name><surname>Krien</surname> <given-names>U</given-names></name><name><surname>Gagov</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Protons inhibit the BK<sub>Ca</sub> channel of rat small artery smooth muscle cells</article-title><source>Journal of Vascular Research</source><volume>38</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1159/000051027</pub-id><pub-id pub-id-type="pmid">11173992</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname> <given-names>KW</given-names></name><name><surname>Skolnick</surname> <given-names>RL</given-names></name><name><surname>Peercy</surname> <given-names>BE</given-names></name><name><surname>Keener</surname> <given-names>JP</given-names></name><name><surname>Vaughan-Jones</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Facilitation of intracellular H<sup>+</sup> ion mobility by CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> in rabbit ventricular myocytes is regulated by carbonic anhydrase</article-title><source>The Journal of Physiology</source><volume>541</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2001.013268</pub-id><pub-id pub-id-type="pmid">12015427</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suinesiaputra</surname> <given-names>A</given-names></name><name><surname>Sanghvi</surname> <given-names>MM</given-names></name><name><surname>Aung</surname> <given-names>N</given-names></name><name><surname>Paiva</surname> <given-names>JM</given-names></name><name><surname>Zemrak</surname> <given-names>F</given-names></name><name><surname>Fung</surname> <given-names>K</given-names></name><name><surname>Lukaschuk</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>AM</given-names></name><name><surname>Carapella</surname> <given-names>V</given-names></name><name><surname>Kim</surname> <given-names>YJ</given-names></name><name><surname>Francis</surname> <given-names>J</given-names></name><name><surname>Piechnik</surname> <given-names>SK</given-names></name><name><surname>Neubauer</surname> <given-names>S</given-names></name><name><surname>Greiser</surname> <given-names>A</given-names></name><name><surname>Jolly</surname> <given-names>M-P</given-names></name><name><surname>Hayes</surname> <given-names>C</given-names></name><name><surname>Young</surname> <given-names>AA</given-names></name><name><surname>Petersen</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fully-automated left ventricular mass and volume MRI analysis in the UK Biobank population cohort: evaluation of initial results</article-title><source>The International Journal of Cardiovascular Imaging</source><volume>34</volume><fpage>281</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1007/s10554-017-1225-9</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname> <given-names>AB</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Aalbaek</surname> <given-names>F</given-names></name><name><surname>Aalkjaer</surname> <given-names>C</given-names></name><name><surname>Boedtkjer</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intracellular acidification alters myogenic responsiveness and vasomotion of mouse middle cerebral arteries</article-title><source>Journal of Cerebral Blood Flow &amp; Metabolism</source><volume>34</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2013.192</pub-id><pub-id pub-id-type="pmid">24192638</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Van Hout</surname> <given-names>CV</given-names></name><name><surname>Tachmazidou</surname> <given-names>I</given-names></name><name><surname>Backman</surname> <given-names>JD</given-names></name><name><surname>Hoffman</surname> <given-names>JX</given-names></name><name><surname>Ye</surname> <given-names>B</given-names></name><name><surname>Pandey</surname> <given-names>AK</given-names></name><name><surname>Gonzaga-Jauregui</surname> <given-names>C</given-names></name><name><surname>Khalid</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Banerjee</surname> <given-names>N</given-names></name><name><surname>Li</surname> <given-names>AH</given-names></name><name><surname>Colm</surname> <given-names>OD</given-names></name><name><surname>Marcketta</surname> <given-names>A</given-names></name><name><surname>Staples</surname> <given-names>J</given-names></name><name><surname>Schurmann</surname> <given-names>C</given-names></name><name><surname>Hawes</surname> <given-names>A</given-names></name><name><surname>Maxwell</surname> <given-names>E</given-names></name><name><surname>Barnard</surname> <given-names>L</given-names></name><name><surname>Lopez</surname> <given-names>A</given-names></name><name><surname>Penn</surname> <given-names>J</given-names></name><name><surname>Habegger</surname> <given-names>L</given-names></name><name><surname>Blumenfeld</surname> <given-names>AL</given-names></name><name><surname>Yadav</surname> <given-names>A</given-names></name><name><surname>Praveen</surname> <given-names>K</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Salerno</surname> <given-names>WJ</given-names></name><name><surname>Chung</surname> <given-names>WK</given-names></name><name><surname>Surakka</surname> <given-names>I</given-names></name><name><surname>Willer</surname> <given-names>CJ</given-names></name><name><surname>Hveem</surname> <given-names>K</given-names></name><name><surname>Leader</surname> <given-names>JB</given-names></name><name><surname>Carey</surname> <given-names>DJ</given-names></name><name><surname>Ledbetter</surname> <given-names>DH</given-names></name><name><surname>Cardon</surname> <given-names>L</given-names></name><name><surname>Yancopoulos</surname> <given-names>GD</given-names></name><name><surname>Economides</surname> <given-names>A</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Shuldiner</surname> <given-names>AR</given-names></name><name><surname>Balasubramanian</surname> <given-names>S</given-names></name><name><surname>Cantor</surname> <given-names>M</given-names></name><name><surname>Nelson</surname> <given-names>MR</given-names></name><name><surname>Whittaker</surname> <given-names>J</given-names></name><name><surname>Reid</surname> <given-names>JG</given-names></name><name><surname>Marchini</surname> <given-names>J</given-names></name><name><surname>Overton</surname> <given-names>JD</given-names></name><name><surname>Scott</surname> <given-names>RA</given-names></name><name><surname>Abecasis</surname> <given-names>G</given-names></name><name><surname>Yerges-Armstrong</surname> <given-names>L</given-names></name><name><surname>Baras</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK biobank</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/572347</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanlandewijck</surname> <given-names>M</given-names></name><name><surname>He</surname> <given-names>L</given-names></name><name><surname>Mäe</surname> <given-names>MA</given-names></name><name><surname>Andrae</surname> <given-names>J</given-names></name><name><surname>Ando</surname> <given-names>K</given-names></name><name><surname>Del Gaudio</surname> <given-names>F</given-names></name><name><surname>Nahar</surname> <given-names>K</given-names></name><name><surname>Lebouvier</surname> <given-names>T</given-names></name><name><surname>Laviña</surname> <given-names>B</given-names></name><name><surname>Gouveia</surname> <given-names>L</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Raschperger</surname> <given-names>E</given-names></name><name><surname>Räsänen</surname> <given-names>M</given-names></name><name><surname>Zarb</surname> <given-names>Y</given-names></name><name><surname>Mochizuki</surname> <given-names>N</given-names></name><name><surname>Keller</surname> <given-names>A</given-names></name><name><surname>Lendahl</surname> <given-names>U</given-names></name><name><surname>Betsholtz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A molecular atlas of cell types and zonation in the brain vasculature</article-title><source>Nature</source><volume>554</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/nature25739</pub-id><pub-id pub-id-type="pmid">29443965</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname> <given-names>NCS</given-names></name><name><surname>Kold-Petersen</surname> <given-names>H</given-names></name><name><surname>Boedtkjer</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Enhanced nitric oxide signaling amplifies vasorelaxation of human Colon cancer feed arteries</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>316</volume><fpage>H245</fpage><lpage>H254</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00368.2018</pub-id><pub-id pub-id-type="pmid">30444664</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname> <given-names>NCS</given-names></name><name><surname>Dreyer</surname> <given-names>T</given-names></name><name><surname>Henningsen</surname> <given-names>MB</given-names></name><name><surname>Vahl</surname> <given-names>P</given-names></name><name><surname>Honoré</surname> <given-names>B</given-names></name><name><surname>Boedtkjer</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeting the acidic tumor microenvironment: unexpected pro-neoplastic effects of oral NaHCO<sub>3</sub> therapy in murine breast tissue</article-title><source>Cancers</source><volume>12</volume><elocation-id>891</elocation-id><pub-id pub-id-type="doi">10.3390/cancers12040891</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahl</surname> <given-names>M</given-names></name><name><surname>Deetjen</surname> <given-names>P</given-names></name><name><surname>Thurau</surname> <given-names>K</given-names></name><name><surname>Ingvar</surname> <given-names>DH</given-names></name><name><surname>Lassen</surname> <given-names>NA</given-names></name></person-group><year iso-8601-date="1970">1970</year><article-title>Micropuncture evaluation of the importance of perivascular pH for the arteriolar diameter on the brain surface</article-title><source>Pflügers Archiv European Journal of Physiology</source><volume>316</volume><fpage>152</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1007/BF00586483</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wemmie</surname> <given-names>JA</given-names></name><name><surname>Price</surname> <given-names>MP</given-names></name><name><surname>Welsh</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Acid-sensing ion channels: advances, questions and therapeutic opportunities</article-title><source>Trends in Neurosciences</source><volume>29</volume><fpage>578</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2006.06.014</pub-id><pub-id pub-id-type="pmid">16891000</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname> <given-names>J</given-names></name><name><surname>Hansen</surname> <given-names>CE</given-names></name><name><surname>Bettoni</surname> <given-names>C</given-names></name><name><surname>Vogt</surname> <given-names>MA</given-names></name><name><surname>Lembrich</surname> <given-names>B</given-names></name><name><surname>Natsagdorj</surname> <given-names>R</given-names></name><name><surname>Huber</surname> <given-names>G</given-names></name><name><surname>Brands</surname> <given-names>J</given-names></name><name><surname>Schmidt</surname> <given-names>K</given-names></name><name><surname>Assmann</surname> <given-names>JC</given-names></name><name><surname>Stölting</surname> <given-names>I</given-names></name><name><surname>Saar</surname> <given-names>K</given-names></name><name><surname>Sedlacik</surname> <given-names>J</given-names></name><name><surname>Fiehler</surname> <given-names>J</given-names></name><name><surname>Ludewig</surname> <given-names>P</given-names></name><name><surname>Wegmann</surname> <given-names>M</given-names></name><name><surname>Feller</surname> <given-names>N</given-names></name><name><surname>Richter</surname> <given-names>M</given-names></name><name><surname>Müller-Fielitz</surname> <given-names>H</given-names></name><name><surname>Walther</surname> <given-names>T</given-names></name><name><surname>König</surname> <given-names>GM</given-names></name><name><surname>Kostenis</surname> <given-names>E</given-names></name><name><surname>Raasch</surname> <given-names>W</given-names></name><name><surname>Hübner</surname> <given-names>N</given-names></name><name><surname>Gass</surname> <given-names>P</given-names></name><name><surname>Offermanns</surname> <given-names>S</given-names></name><name><surname>de Wit</surname> <given-names>C</given-names></name><name><surname>Wagner</surname> <given-names>CA</given-names></name><name><surname>Schwaninger</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Impaired endothelium-mediated cerebrovascular reactivity promotes anxiety and respiration disorders in mice</article-title><source>PNAS</source><volume>117</volume><fpage>1753</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1073/pnas.1907467117</pub-id><pub-id pub-id-type="pmid">31896584</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Hogan</surname> <given-names>EM</given-names></name><name><surname>Bevensee</surname> <given-names>MO</given-names></name><name><surname>Boron</surname> <given-names>WF</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Out-of-equilibrium CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> solutions and their use in characterizing a new K/HCO<sub>3</sub> cotransporter</article-title><source>Nature</source><volume>374</volume><fpage>636</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1038/374636a0</pub-id><pub-id pub-id-type="pmid">7715702</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Skelton</surname> <given-names>LA</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Chandler</surname> <given-names>MP</given-names></name><name><surname>Berthiaume</surname> <given-names>JM</given-names></name><name><surname>Boron</surname> <given-names>WF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Role of receptor protein tyrosine phosphatase γ in sensing extracellular CO<sub>2</sub> and HCO<sub>3</sub><sup>–</sup></article-title><source>Journal of the American Society of Nephrology : JASN</source><volume>27</volume><fpage>2616</fpage><lpage>2621</lpage><pub-id pub-id-type="doi">10.1681/ASN.2015040439</pub-id><pub-id pub-id-type="pmid">26839367</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57553.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Mangoni</surname><given-names>Arduino A</given-names></name><role>Reviewing Editor</role><aff><institution>Flinders Medical Centre</institution><country>Australia</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Mangoni</surname><given-names>Arduino A</given-names></name><role>Reviewer</role><aff><institution>Flinders Medical Centre</institution><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The manuscript describes the role of the receptor protein tyrosine phosphatase γ (RPTPγ) on vascular functions that are related to the sensing of acid-base disturbances. The main experiments are performed on RPTPγ knockout mice and complemented by an analysis of the correlation between <italic>PTPRG</italic> loss-of-function variations with ischaemic events at the population level.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>PTPRG</italic> is an ischemia risk locus essential for HCO<sub>3</sub><sup>-</sup>dependent regulation of endothelial function and tissue perfusion&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Arduino A Mangoni as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Matthias Barton as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>The manuscript describes the role of the receptor protein tyrosine phosphatase γ (RPTPγ) on vascular functions that are related to the sensing of acid-base disturbances. The main experiments are performed on RPTPγ knockout mice and complemented by an analysis of the correlation between <italic>PTPRG</italic> loss-of-function variations with ischemic events at the population level. The study is thoroughly performed and contributes significant knowledge to the field.</p><p>Essential revisions:</p><p>– Unusually, CO2/HCO<sub>3</sub> buffer was prepared with Hepes. Such a dual buffer system provides high buffering power (twice the physiological). Can the authors clarify how the buffer was prepared? Was the pH of Hepes titrated before or after CO2/HCO<sub>3</sub> addition, as this has a major effect on the equilibrium pH. It would seem important to include a 3-arm where the medium has CO2/HCO<sub>3</sub> but no Hepes (i.e. to match buffering to Hepes-only).</p><p>– Hepes itself can produce effects on vessel contractility (PMID: 6254589); it would be important to confirm that the inclusion of Hepes did not affect RTPTγ signalling. Indeed, some early evidence suggested that Hepes blocks CAs (PMID: 1904692), and given the similarity to RTPTγ, such an interaction with endothelial targets should be tested. This could be tested in animals with CO<sub>2</sub>/HCO<sub>3</sub> buffers that do not contain Hepes, and compare with Hepes (see also above).</p><p>– The removal of CO2/HCO<sub>3</sub> buffer is likely to change intracellular pH (inactivation of pH regulators, drawing out an acidic gas). In the absence of a RTPTγ antagonist (for rescue), it seems important to check the degree to which cell pH is changing upon the buffer change, and to what degree this could explain the phenotype. This would have actions in both KO and WT, thus cannot alone explain the phenotype.</p><p>– The effect of SNP on NHE is likely not unique to this donor, and a similar effect would be attributed to other donors (via NO acting on NHE1). A more likely explanation seems that SNP can produce cyanide at high doses. As SNP may have these actions, it may be advisable to take this dataset out, as it is mechanistically inconclusive.</p><p>– When reporting results, the authors use present tense. I would recommend past tense because it emphasizes the historic nature of the observation.</p><p>– When hyperventilating mice, HCO<sub>3</sub><sup>-</sup> concentrations marginally dropped from 20.4 mmol/l to 19.0 mmol/l in wild-type mice. The authors claim that this small change could make the blood pressure RPTPγ-sensitive. This conclusion should be down toned.</p><p>– In hyperventilated mice, the blood pressure is lower in RPTPγ KO mice than in wild-type controls because the dilatory effect of RPTPγ is missing. If RPTPγ is a HCO<sub>3</sub><sup>-</sup> sensor, why does this effect become evident when HCO<sub>3</sub><sup>-</sup> concentrations are lowered? The same question arises for the experiment depicted in Figure 5F. The authors' conclusion seems to be based on some additional assumption that is not clearly stated.</p><p>– The finding on the neurovascular coupling is interesting. As this mechanism unlike hyperventilation comprises a local response and is limited to the brain area where neuronal activity occurs it would be interesting to know whether RPTPγ is also expressed in smaller arterioles or capillaries. The data of Kalucka et al., 2020, suggest that capillaries also express RPTPγ. If this is not true, the role of this enzyme in other cell types than endothelial cells like neurons or astrocytes during neurovascular coupling could be discussed.</p><p>– UK Biobank data analysis. The reported differences between cases and controls after age- and sex-matching is a useful initial step. However, the authors should conduct additional analyses after correcting for other clinical characteristics, particularly smoking, diabetes, hypertension, dyslipidemia, and history of previous cardiovascular events.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57553.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>– Unusually, CO2/HCO<sub>3</sub> buffer was prepared with Hepes. Such a dual buffer system provides high buffering power (twice the physiological). Can the authors clarify how the buffer was prepared? Was the pH of Hepes titrated before or after CO2/HCO<sub>3</sub> addition, as this has a major effect on the equilibrium pH. It would seem important to include a 3-arm where the medium has CO2/HCO<sub>3</sub> but no Hepes (i.e. to match buffering to Hepes-only).</p></disp-quote><p>As we now explain in the manuscript (subsections “RPTPγ enhances endothelium-dependent vasorelaxation” and “Small vessel myography”), we included HEPES in the CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing experimental solutions because we – being aware of previously reported unspecific effects – wanted to allow for comparison with experiments performed in CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free solutions, where the addition of an artificial buffer is unavoidable (see also the next point, below). In order to address the concern raised by the reviewers, we have now performed an additional series of experiments based on CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solutions without HEPES; and under these conditions, we corroborate that knockout of RPTPγ inhibits endothelium-dependent vasorelaxation (Figures 2C and 3C).</p><p>Regarding preparation of the experimental solutions, we adjusted pH after both HEPES and CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> were added: after mixing all the ingredients, we heated the solutions to 37°C, bubbled aggressively with 5% CO<sub>2</sub>/balance air (HCO<sub>3</sub><sup>–</sup>-containing solutions) or nominally CO<sub>2</sub>-free medical air (HCO<sub>3</sub><sup>–</sup>-free solutions) – and then titrated the solutions to pH 7.40 while allowing sufficient time for the buffer systems to equilibrate. Although, this procedure is obvious to acid-base physiologists, we appreciate that <italic>eLife</italic> has a broader readership, and we have therefore now included these additional details in the manuscript (subsection “Small vessel myography”).</p><disp-quote content-type="editor-comment"><p>– Hepes itself can produce effects on vessel contractility (PMID: 6254589); it would be important to confirm that the inclusion of Hepes did not affect RTPTγ signalling. Indeed, some early evidence suggested that Hepes blocks CAs (PMID: 1904692), and given the similarity to RTPTγ, such an interaction with endothelial targets should be tested. This could be tested in animals with CO<sub>2</sub>/HCO<sub>3</sub> buffers that do not contain Hepes, and compare with Hepes (see also above).</p></disp-quote><p>We acknowledge that HEPES has been reported to affect vessel contractility. In fact, as explained above, this was a main reason for including HEPES in both CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-free and CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solutions thus allowing us to distinguish effects of omitting CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> from potential effects of adding HEPES. In order to address the concern raised by the reviewers, we have now performed an additional series of experiments based on CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>-containing solutions without HEPES; and these data corroborate that also under conditions with no HEPES present, knockout of RPTPγ inhibits endothelium-dependent vasorelaxation (Figures 2C and 3C).</p><disp-quote content-type="editor-comment"><p>– The removal of CO2/HCO<sub>3</sub> buffer is likely to change intracellular pH (inactivation of pH regulators, drawing out an acidic gas). In the absence of a RTPTγ antagonist (for rescue), it seems important to check the degree to which cell pH is changing upon the buffer change, and to what degree this could explain the phenotype. This would have actions in both KO and WT, thus cannot alone explain the phenotype.</p></disp-quote><p>This is indeed an important and relevant point, and we have now measured intracellular pH of endothelial cells in mesenteric and basilar arteries and evaluated the intracellular pH response to buffer change (Figure 5P and Q). We find that RPTPγ knockout does not influence endothelial steady-state intracellular pH, and we furthermore corroborate previous evidence from C57BL/6 mice (Boedtkjer et al., 2011; Boedtkjer, Damkier and Aalkjaer, 2012) demonstrating that omission of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> has no net effect on steady-state intracellular pH in endothelial cells. The effect of CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup> omission on steady-state pH<sub>i</sub> depends on the relative activity of HCO<sub>3</sub><sup>-</sup> uptake (e.g., Na<sup>+</sup>,HCO<sub>3</sub><sup>–</sup>-cotransporters) and HCO<sub>3</sub><sup>–</sup> extrusion (e.g., Cl<sup>–</sup>/HCO<sub>3</sub><sup>–</sup>-exchangers) mechanisms – and varies amongst cell types and between mice on different genetic backgrounds. In mice on C57BL/6 genetic background, we consistently see no net steady-state difference in endothelial intracellular pH between experiments performed with and without CO<sub>2</sub>/HCO<sub>3</sub><sup>–</sup>.</p><disp-quote content-type="editor-comment"><p>– The effect of SNP on NHE is likely not unique to this donor, and a similar effect would be attributed to other donors (via NO acting on NHE1). A more likely explanation seems that SNP can produce cyanide at high doses. As SNP may have these actions, it may be advisable to take this dataset out, as it is mechanistically inconclusive.</p></disp-quote><p>We appreciate this suggestion and have removed the data set with SNP (Figure 5).</p><disp-quote content-type="editor-comment"><p>– When reporting results, the authors use present tense. I would recommend past tense because it emphasizes the historic nature of the observation.</p></disp-quote><p>We have now changed the reporting of the results from present to past tense as suggested (see Results section).</p><disp-quote content-type="editor-comment"><p>– When hyperventilating mice, HCO<sub>3</sub><sup>-</sup> concentrations marginally dropped from 20.4 mmol/l to 19.0 mmol/l in wild-type mice. The authors claim that this small change could make the blood pressure RPTPγ-sensitive. This conclusion should be down toned.</p></disp-quote><p>Although our data support that systemic changes in [HCO<sub>3</sub><sup>–</sup>] influence blood pressure, we appreciate that the observed changes in [HCO<sub>3</sub><sup>–</sup>] are relatively small and have therefore followed the recommendation of the reviewers to tone down this conclusion (subsection “RPTPγ amplifies hyperventilation-induced blood pressure elevations”).</p><disp-quote content-type="editor-comment"><p>– In hyperventilated mice, the blood pressure is lower in RPTPγ KO mice than in wild-type controls because the dilatory effect of RPTPγ is missing. If RPTPγ is a HCO<sub>3</sub><sup>-</sup> sensor, why does this effect become evident when HCO<sub>3</sub><sup>-</sup> concentrations are lowered? The same question arises for the experiment depicted in Figure 5F. The authors' conclusion seems to be based on some additional assumption that is not clearly stated.</p></disp-quote><p>We have now included a discussion of how the unaltered resting blood pressure in RPTPγ KO mice (Figure 6A) most likely reflects that numerous mechanisms are involved in blood pressure control and that compensation—e.g., through nervous, hormonal or renal influences—can maintain blood pressure in the sustained phase and mask hemodynamic consequences of RPTPγ except when acute acid-base disturbances are imposed (Discussion, second paragraph).</p><disp-quote content-type="editor-comment"><p>– The finding on the neurovascular coupling is interesting. As this mechanism unlike hyperventilation comprises a local response and is limited to the brain area where neuronal activity occurs it would be interesting to know whether RPTPγ is also expressed in smaller arterioles or capillaries. The data of Kalucka et al., 2020, suggest that capillaries also express RPTPγ. If this is not true, the role of this enzyme in other cell types than endothelial cells like neurons or astrocytes during neurovascular coupling could be discussed.</p></disp-quote><p>Indeed the data of Kalucka et al., 2020, support that RPTPγ is broadly expressed in endothelial cells from arteries, capillaries, and the venous system. Based on the data from Kalucka et al. – that are publicly available through the EC Database at https://endotheliomics.shinyapps.io/ec_atlas/ – we have now expanded Figure 1 to show the endothelial expression patterns in different vascular beds and blood vessels of various sizes (Figure 1C-E).</p><disp-quote content-type="editor-comment"><p>– UK Biobank data analysis. The reported differences between cases and controls after age- and sex-matching is a useful initial step. However, the authors should conduct additional analyses after correcting for other clinical characteristics, particularly smoking, diabetes, hypertension, dyslipidemia, and history of previous cardiovascular events.</p></disp-quote><p>We thank the reviewers for these suggestions and have now thoroughly revised and updated the UK Biobank analysis. The following changes were done:</p><p>a) The initial genetic analysis of the exome variants within <italic>PTPRG</italic> was based on the SPB pipeline (see van Hout et al., 2019). It is now known that the SPB pipeline did not correctly identify genetic variants, which is why this data set has been retracted and replaced by a new genetic data set generated using the Functionally Equivalent pipeline (PMID: 30279509). For our study, this means that the number of genetic variants was reduced from 80 to 75 predicted loss-of-function (pLOF) variants in <italic>PTPRG</italic>.</p><p>b) Besides the errors within the original release of the UK Biobank exome data, we unfortunately observed another error relating to the extraction of individuals carrying pLOF variants. In our original report we stated that a total of 1,288 individuals were carrying at least one pLOF variant. This is not correct. We used an earlier version of the R package qgg (PMID: 31883004) to extract genotypes and phenotypes, which at that time had an issue reading the data correctly (such that individuals with missing genotypes were included). The package has been updated, and we have now extracted the correct information.</p><p>c) Since our first submission, seven UK Biobank participants have withdrawn their consent, and as a consequence we had to remove these individuals from our analysis.</p><p>d) In addition to these corrections, we have now also extracted additional information from the UK Biobank to allow us to conduct new analyses where we correct for sex, age, body mass index, genetic principal component, smoking status, dyslipidemia, diabetes mellitus, and hypertension. To best perform these analyses, we now test differences based on logistic regression analyses (Figure 7A-C) or multiple linear regression analyses (Figure 7D).</p><p>e) In the original analyses, we divided the UK Biobank participants between controls and carriers of any <italic>PTPRG</italic> pLOF variant irrespective of its predicted severity. In the new analysis, we have used additional information dividing the pLOF carriers into those with low, moderate, and high predicted impact.</p><p>f) We have now also expanded the analyses to include self-reported health status (Figure 7C) and left ventricular ejection fraction (Figure 7D).</p></body></sub-article></article>